JPH1129557A - Pyrimidine derivative, liquid crystal composition containing the same and liquid crystal display element using the same - Google Patents
Pyrimidine derivative, liquid crystal composition containing the same and liquid crystal display element using the sameInfo
- Publication number
- JPH1129557A JPH1129557A JP9197821A JP19782197A JPH1129557A JP H1129557 A JPH1129557 A JP H1129557A JP 9197821 A JP9197821 A JP 9197821A JP 19782197 A JP19782197 A JP 19782197A JP H1129557 A JPH1129557 A JP H1129557A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- liquid crystal
- atom
- formula
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 151
- 239000000203 mixture Substances 0.000 title claims abstract description 135
- 150000003230 pyrimidines Chemical class 0.000 title claims description 20
- 150000001875 compounds Chemical class 0.000 claims abstract description 272
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 211
- 125000001153 fluoro group Chemical group F* 0.000 claims abstract description 31
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims abstract description 18
- -1 pyrimidin-2,5-diyl group Chemical group 0.000 claims abstract description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 41
- 125000000217 alkyl group Chemical group 0.000 claims description 25
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 125000005407 trans-1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])[C@]([H])([*:2])C([H])([H])C([H])([H])[C@@]1([H])[*:1] 0.000 claims description 12
- 125000005843 halogen group Chemical group 0.000 claims description 11
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 8
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 claims description 6
- 125000004429 atom Chemical group 0.000 claims description 5
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 125000005714 2,5- (1,3-dioxanylene) group Chemical group [H]C1([H])OC([H])([*:1])OC([H])([H])C1([H])[*:2] 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- JCBJVAJGLKENNC-UHFFFAOYSA-N potassium;ethoxymethanedithioic acid Chemical compound [K+].CCOC(S)=S JCBJVAJGLKENNC-UHFFFAOYSA-N 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 20
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 4
- 229910052736 halogen Inorganic materials 0.000 abstract description 3
- 150000002367 halogens Chemical class 0.000 abstract description 3
- 239000011592 zinc chloride Substances 0.000 abstract description 3
- 235000005074 zinc chloride Nutrition 0.000 abstract description 3
- 239000010409 thin film Substances 0.000 abstract description 2
- 230000007704 transition Effects 0.000 description 18
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 17
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- 230000000704 physical effect Effects 0.000 description 10
- 125000005647 linker group Chemical group 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 8
- 230000002194 synthesizing effect Effects 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 150000004795 grignard reagents Chemical class 0.000 description 5
- 125000000714 pyrimidinyl group Chemical group 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- AFNXIXFXBIVDOY-UHFFFAOYSA-N 2-[3,5-difluoro-4-[3-fluoro-4-(trifluoromethoxy)phenyl]phenyl]-5-pentylpyrimidine Chemical compound N1=CC(CCCCC)=CN=C1C1=CC(F)=C(C=2C=C(F)C(OC(F)(F)F)=CC=2)C(F)=C1 AFNXIXFXBIVDOY-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- PMKFPIVBZBYDJQ-UHFFFAOYSA-N 2-(3,5-difluorophenyl)-5-pentylpyrimidine Chemical compound N1=CC(CCCCC)=CN=C1C1=CC(F)=CC(F)=C1 PMKFPIVBZBYDJQ-UHFFFAOYSA-N 0.000 description 3
- VUHGHNDGAOCPNP-UHFFFAOYSA-N 2-ethoxyoct-7-ynal Chemical compound CCOC(C=O)CCCCC#C VUHGHNDGAOCPNP-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- 239000007818 Grignard reagent Substances 0.000 description 2
- 239000004988 Nematic liquid crystal Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000013213 extrapolation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- UGOCNHASEZIJFQ-UHFFFAOYSA-N 1,1-diethoxyheptane Chemical compound CCCCCCC(OCC)OCC UGOCNHASEZIJFQ-UHFFFAOYSA-N 0.000 description 1
- LQQUELXLCCXQAX-UHFFFAOYSA-N 1,2-difluoro-4-[4-[2-(4-pentylcyclohexyl)ethyl]cyclohexyl]benzene Chemical compound C1CC(CCCCC)CCC1CCC1CCC(C=2C=C(F)C(F)=CC=2)CC1 LQQUELXLCCXQAX-UHFFFAOYSA-N 0.000 description 1
- HTAPXFSKUGZEEP-UHFFFAOYSA-N 1,2-difluoro-4-[4-[2-(4-propylcyclohexyl)ethyl]cyclohexyl]benzene Chemical compound C1CC(CCC)CCC1CCC1CCC(C=2C=C(F)C(F)=CC=2)CC1 HTAPXFSKUGZEEP-UHFFFAOYSA-N 0.000 description 1
- LVEYOSJUKRVCCF-UHFFFAOYSA-N 1,3-Bis(diphenylphosphino)propane Substances C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 LVEYOSJUKRVCCF-UHFFFAOYSA-N 0.000 description 1
- JHLKSIOJYMGSMB-UHFFFAOYSA-N 1-bromo-3,5-difluorobenzene Chemical compound FC1=CC(F)=CC(Br)=C1 JHLKSIOJYMGSMB-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- WMARUIMXVALOMF-UHFFFAOYSA-N 2-chloro-5-pentylpyrimidine Chemical compound CCCCCC1=CN=C(Cl)N=C1 WMARUIMXVALOMF-UHFFFAOYSA-N 0.000 description 1
- NIQYHKFKPNBQPE-UHFFFAOYSA-N 2-pentylpyrimidine Chemical compound CCCCCC1=NC=CC=N1 NIQYHKFKPNBQPE-UHFFFAOYSA-N 0.000 description 1
- NSGMZTNTQKRAFA-UHFFFAOYSA-N 4-(4-heptylcyclohexyl)benzonitrile Chemical compound C1CC(CCCCCCC)CCC1C1=CC=C(C#N)C=C1 NSGMZTNTQKRAFA-UHFFFAOYSA-N 0.000 description 1
- FURZYCFZFBYJBT-UHFFFAOYSA-N 4-(4-pentylcyclohexyl)benzonitrile Chemical compound C1CC(CCCCC)CCC1C1=CC=C(C#N)C=C1 FURZYCFZFBYJBT-UHFFFAOYSA-N 0.000 description 1
- XXUSEPRYHRDKFV-UHFFFAOYSA-N 4-(4-propylcyclohexyl)benzonitrile Chemical compound C1CC(CCC)CCC1C1=CC=C(C#N)C=C1 XXUSEPRYHRDKFV-UHFFFAOYSA-N 0.000 description 1
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
- KYYJIBTUSXSVOK-UHFFFAOYSA-N 4-[4-[2-(4-ethylcyclohexyl)ethyl]cyclohexyl]-1,2-difluorobenzene Chemical compound C1CC(CC)CCC1CCC1CCC(C=2C=C(F)C(F)=CC=2)CC1 KYYJIBTUSXSVOK-UHFFFAOYSA-N 0.000 description 1
- SBSFDYRKNUCGBZ-UHFFFAOYSA-N 4-bromo-2-fluoro-1-(trifluoromethoxy)benzene Chemical compound FC1=CC(Br)=CC=C1OC(F)(F)F SBSFDYRKNUCGBZ-UHFFFAOYSA-N 0.000 description 1
- ZZBXRDLMKHGLAP-UHFFFAOYSA-N 5-pentyl-1h-pyrimidin-2-one Chemical compound CCCCCC=1C=NC(=O)NC=1 ZZBXRDLMKHGLAP-UHFFFAOYSA-N 0.000 description 1
- NYFZWXPJKYCSKK-UHFFFAOYSA-N 5-pentyl-2-[4-(3,4,5-trifluorophenyl)phenyl]pyrimidine Chemical compound N1=CC(CCCCC)=CN=C1C1=CC=C(C=2C=C(F)C(F)=C(F)C=2)C=C1 NYFZWXPJKYCSKK-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 239000004983 Polymer Dispersed Liquid Crystal Substances 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 239000004990 Smectic liquid crystal Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 description 1
- 125000005337 azoxy group Chemical group [N+]([O-])(=N*)* 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000012320 chlorinating reagent Substances 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 1
- 239000004815 dispersion polymer Substances 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000005262 ferroelectric liquid crystals (FLCs) Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3441—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
- C09K19/345—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing two nitrogen atoms
- C09K19/3458—Uncondensed pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3441—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
- C09K19/345—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing two nitrogen atoms
- C09K19/3458—Uncondensed pyrimidines
- C09K19/3469—Pyrimidine with a specific end-group other than alkyl, alkoxy or -C*-
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/42—Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/42—Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
- C09K19/44—Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40 containing compounds with benzene rings directly linked
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/42—Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
- C09K19/46—Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40 containing esters
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K2019/0444—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
- C09K2019/0448—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K2019/0444—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
- C09K2019/0451—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a CH3CH=CHCH2CH2- chain
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2323/00—Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Liquid Crystal Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、新規な液晶性化合
物(以下、液晶性化合物なる用語は液晶相を有する化合
物および液晶相を示さないが液晶組成物の構成成分とし
た有用な化合物の総称として用いる。)、特にTFT型
液晶表示素子用液晶組成物の成分として用いるのに好適
な液晶性化合物、この化合物を含有するむ液晶組成物、
およびこの液晶組成物を用いて構成した液晶表示素子に
関する。The present invention relates to a novel liquid crystal compound (hereinafter, the term "liquid crystal compound" is a general term for compounds having a liquid crystal phase and useful compounds which do not show a liquid crystal phase but are used as constituents of liquid crystal compositions). ), A liquid crystal compound particularly suitable for use as a component of a liquid crystal composition for a TFT type liquid crystal display element, a liquid crystal composition containing this compound,
And a liquid crystal display device formed using the liquid crystal composition.
【0002】[0002]
【背景技術】液晶表示素子は液晶物質がもつ光学異方性
および誘電率異方性を利用したものであるが、その表示
方式によってTN(ねじれネマチック)モード、DS
(動的散乱)モード、G・H(ゲスト・ホストもー
ど)、DAP(配向相変)モード、STN(超ねじれネ
マチック)モードなどの表示方式がある。 最近、より
高い表示品位のの要求に応えるために、薄膜トランジス
タ(TFT)に代表されるアクティブマトリックス方式
の表示素子の需要が高まっている。各表示方式ごとに液
晶物質に要求する性能は異なるが、いずれの表示素子に
用いられる液晶物質も水分、空気、熱、光等に安定であ
ることが必要であるうえ、室温を中心としてできるだけ
広い温度範囲で液晶相を示し、低粘性であり、他の液晶
性化合物との相溶性がよく、大きな誘電率異方性値(Δ
ε)を持ち、最適な屈折率異方性値(Δn)を有し、化
学的、電気的に安定でなければならない。特に、アクテ
ィブマトリックス方式の表示素子には高い電圧保持率が
要求されている。しかし現在のところ単一化合物ではこ
のような条件をすべて満たす物質はなく、数種の液晶化
合物や液晶性化合物を混合して得られる液晶組成物を使
用しているのが現状である。2. Description of the Related Art A liquid crystal display device utilizes an optical anisotropy and a dielectric anisotropy of a liquid crystal material. Depending on the display method, a TN (twisted nematic) mode, a DS
There are display methods such as (dynamic scattering) mode, GH (guest / host), DAP (orientation phase change) mode, and STN (super twisted nematic) mode. In recent years, in order to meet the demand for higher display quality, the demand for an active matrix type display element represented by a thin film transistor (TFT) is increasing. The performance required of the liquid crystal material is different for each display method, but the liquid crystal material used in any display element must be stable to moisture, air, heat, light, etc., and should be as wide as possible around room temperature. Shows a liquid crystal phase in a temperature range, has low viscosity, has good compatibility with other liquid crystal compounds, and has a large dielectric anisotropy value (Δ
ε), have an optimum refractive index anisotropy value (Δn), and be chemically and electrically stable. In particular, a high voltage holding ratio is required for an active matrix type display element. However, at present, no single compound satisfies all of these conditions, and at present, a liquid crystal composition obtained by mixing several types of liquid crystal compounds or liquid crystal compounds is used.
【0003】最近ではTFT型液晶表示素子において、
低電圧駆動で応答速度の速いものが求められている。こ
のため高い電圧保持率を示し、かつ大きなΔnと大きな
Δεを有する液晶材料の開発が活発に行われている。こ
れまでにフッ素置換された液晶材料が高い電圧保持率を
示すこと、および複数の芳香環を含有する液晶性化合物
が大きなΔnを有することが知られている。芳香環がピ
リミジン環である化合物は大きなΔεを有することも知
られている。このような知識に基づけば、ピリミジン環
を有し、フッ素置換された液晶性化合物は大きなΔnと
大きなΔεを併せ持ち、かつ電圧保持率も高いことが予
想される。特開平2−233626号には、ピリミジン
環を有しかつフッ素置換された液晶性化合物(化合物
(10))が開示されている。Recently, in a TFT type liquid crystal display device,
There is a demand for a low-voltage drive and a high response speed. Therefore, liquid crystal materials exhibiting a high voltage holding ratio and having a large Δn and a large Δε are being actively developed. It has been known that a fluorine-substituted liquid crystal material shows a high voltage holding ratio and that a liquid crystal compound containing a plurality of aromatic rings has a large Δn. It is also known that compounds in which the aromatic ring is a pyrimidine ring have a large Δε. Based on such knowledge, it is expected that a fluorine-substituted liquid crystalline compound having a pyrimidine ring has both a large Δn and a large Δε and a high voltage holding ratio. JP-A-2-233626 discloses a fluorine-substituted liquid crystal compound (compound (10)) having a pyrimidine ring.
【0004】[0004]
【化5】 Embedded image
【0005】特開平2−233626号の記載にしたが
って本発明者らが合成し、測定した化合物(10)の電
圧保持率は25℃で97.5%、100℃で92.9%
であった。また、ネマチック相を有する母液晶に化合物
(10)を溶解して得られた組成物と母液晶のそれぞれ
の物性値および混合比から、外挿法で算出した化合物
(10)の物性値は、N−I転移点が83.7℃、Δε
が18.7、Δnが0.204という値であった。この
ものは比較的高い電圧保持率を有しているが、液晶表示
素子の低電圧駆動への要求に応えるには、Δεの値は不
十分である。そのうえ、後に比較例の項に示したよう
に、化合物(10)は他の液晶性化合物との低温相溶性
が悪いという欠点を有している。低温相溶性が悪い液晶
材料は、液晶組成物中の混合比を大きくできないので、
他に優れた特性を有していてもその特性を液晶組成物の
特性の向上に寄与できない。The voltage holding ratio of the compound (10) synthesized and measured by the present inventors according to the description in JP-A-2-233626 is 97.5% at 25 ° C. and 92.9% at 100 ° C.
Met. The physical properties of the compound (10) calculated by the extrapolation method from the respective physical properties and the mixing ratio of the composition obtained by dissolving the compound (10) in the mother liquid crystal having a nematic phase and the mother liquid crystal are as follows: NI transition point is 83.7 ° C, Δε
Was 18.7 and Δn was 0.204. Although this has a relatively high voltage holding ratio, the value of Δε is insufficient to meet the demand for low-voltage driving of the liquid crystal display device. In addition, as will be described later in the section of the comparative example, the compound (10) has a disadvantage that the low-temperature compatibility with other liquid crystal compounds is poor. Liquid crystal materials with poor low-temperature compatibility cannot increase the mixing ratio in the liquid crystal composition,
Even if it has other excellent characteristics, it cannot contribute to the improvement of the characteristics of the liquid crystal composition.
【0006】[0006]
【発明が解決しようとする課題】本発明の目的は、高い
電圧保持率、大きなΔn、及び大きなΔεを有し、か
つ、他の液晶性化合物との低温相溶性に優れる液晶性化
合物、これを含む液晶組成物、およびこれを用いて構成
した液晶表示素子を提供することにある。SUMMARY OF THE INVENTION An object of the present invention is to provide a liquid crystal compound having a high voltage holding ratio, a large Δn and a large Δε, and having excellent low-temperature compatibility with other liquid crystal compounds. It is another object of the present invention to provide a liquid crystal composition containing the same, and a liquid crystal display device formed using the same.
【0007】[0007]
【課題を解決するための手段】本発明者らは、かかる目
的を達成するために鋭意検討した結果、ラテラル位に少
なくとも1個のフッ素原子が置換された1,4−フェニ
レン基とピリミジン−2,5−ジイル基を有する一般式
(1)で表される化合物が所期の性能を有する液晶性化
合物であることを見いだし、本発明を完成するに至っ
た。すなわち本発明は以下の通りである。 (1)一般式(1)Means for Solving the Problems The present inventors have conducted intensive studies in order to achieve the above object, and as a result, have found that a 1,4-phenylene group having at least one fluorine atom substituted at the lateral position and pyrimidine-2. The present inventors have found that the compound represented by the general formula (1) having a 5,5-diyl group is a liquid crystal compound having expected performance, and have completed the present invention. That is, the present invention is as follows. (1) General formula (1)
【0008】[0008]
【化6】 Embedded image
【0009】(式中、Rは水素原子、または炭素数1〜
20のアルキル基を示すが、このアルキル基中の1個以
上の水素原子はハロゲン原子で置換されていてもよく、
基中の1個以上の−CH2−は酸素原子または−CH2=
CH2−で置換されていてもよいが、酸素原子が隣接す
ることはなく;n1およびn2はそれぞれ独立して0、
1、または2であるが、n1とn2の和は1または2であ
り;環Aおよび環Bはそれぞれに独立して1,4−フェ
ニレン、式(a)で表されるフッ素置換1,4−フェニ
レン、または1,4−シクロヘキシレンを示すが、環A
および環Bの少なくとも一方は式(a)で表されるフッ
素置換1,4−フェニレンであり、かつこのフッ素置換
1,4−フェニレンに対応するn1および/またはn2は
1または2であり、1,4−シクロヘキシレンは基中の
相隣接しない1個以上の−CH2−は酸素原子で置換さ
れていてもよく、また1,4−シクロヘキシレンは基中
の1個以上の水素原子はハロゲン原子で置換されていて
もよく;Za、Zb、およびZcはそれぞれに独立して
単結合、−CH2CH2−、−COO−、−CF2O−あ
るいは−CH2CH2CH2CH2−を示し;Q1、Q2、Q
3、Q4、Q5、Q6およびQ7はそれぞれに独立して水素
原子、ハロゲン原子あるいはメチル基を示すが、Za、
ZbおよびZcの少なくとも1個が−CH2CH2−の場
合はQ2はフッ素原子であり;Yは水素原子、ハロゲン
原子、または炭素数1〜5のハロゲン化アルキル基を示
すが、このハロゲン化アルキル基中の相隣接しない1つ
以上のメチレン基は酸素原子あるいは硫黄原子で置換さ
れていてもよく;また、この化合物を構成する各元素は
その同位体で置換されていてもよい。)で表されるピリ
ミジン誘導体。(Wherein R represents a hydrogen atom or a group having 1 to 1 carbon atoms)
20 represents an alkyl group, wherein one or more hydrogen atoms in the alkyl group may be substituted with a halogen atom;
One or more —CH 2 — in the group is an oxygen atom or —CH 2 =
CH 2 — may be substituted, but no oxygen atom is adjacent; n 1 and n 2 are each independently 0,
And the sum of n1 and n2 is 1 or 2, and ring A and ring B are each independently 1,4-phenylene, a fluorine-substituted 1,4 represented by the formula (a). -Phenylene or 1,4-cyclohexylene, but a ring A
And at least one of the ring B is a fluorine-substituted 1,4-phenylene represented by the formula (a), and n1 and / or n2 corresponding to the fluorine-substituted 1,4-phenylene are 1 or 2; In 1,4-cyclohexylene, one or more non-adjacent —CH 2 — in the group may be substituted with an oxygen atom, and 1,4-cyclohexylene has one or more hydrogen atoms in the group being halogen. may be substituted with atoms; Za, Zb, and Zc are independently a single bond, respectively, -CH 2 CH 2 -, - COO -, - CF 2 O- or -CH 2 CH 2 CH 2 CH 2 - indicates; Q 1, Q 2, Q
3 , Q 4 , Q 5 , Q 6 and Q 7 each independently represent a hydrogen atom, a halogen atom or a methyl group;
When at least one of Zb and Zc is —CH 2 CH 2 —, Q 2 is a fluorine atom; Y represents a hydrogen atom, a halogen atom, or a halogenated alkyl group having 1 to 5 carbon atoms. One or more non-adjacent methylene groups in the alkylated alkyl group may be substituted with an oxygen atom or a sulfur atom; and each element constituting the compound may be substituted with its isotope. A) a pyrimidine derivative represented by the formula:
【0010】(2) 一般式(1)において、n1が0
であり、n2が1であり、Za、ZbおよびZcがすべ
て単結合であり、Q1とQ3が共に水素原子であり、Q2
がフッ素原子である(1)項に記載のピリミジン誘導
体。 (3) 一般式(1)において、n1が0であり、n2が
1であり、Za、ZbおよびZcがすべて単結合であ
り、Q1、Q2およびQ3がすべて水素原子である(1)
項に記載のピリミジン誘導体。 (4) 一般式(1)において、n1が1であり、n2が
0である(1)項に記載のピリミジン誘導体。 (5) 一般式(1)において、n1が0であり、n2が
1であり、ZaおよびZbが共に単結合であり、Zcが
−COO−または−CF2O−である(1)項に記載の
ピリミジン誘導体。 (6) 一般式(1)において、n1が0であり、n2が
1であり、ZaおよびZcが共に単結合であり、Zbが
−COO−または−CF2O−である(1)項に記載の
ピリミジン誘導体。 (7) 一般式(1)において、n1+n2=2である
(1)項に記載のピリミジン誘導体。 (8) 一般式(1)において、Rが基中の1個以上の
水素原子がフッ素で置換されたアルキル基である(1)
項に記載のピリミジン誘導体。 (9) (1)項から(8)項のいずれか1項に記載の
ピリミジン誘導体を少なくとも1種類含有することを特
徴とする液晶組成物。 (10) 第一成分として、(1)項から(8)項のい
ずれか1項に記載の化合物を少なくとも1種類含有し、
第二成分として、一般式(2)、(3)および(4)(2) In the general formula (1), n1 is 0
And n2 is 1, Za, Zb and Zc are all single bonds, Q 1 and Q 3 are both hydrogen atoms, Q 2
Is a fluorine atom. (3) In the general formula (1), n1 is 0, n2 is 1, Za, Zb and Zc are all single bonds, Q 1, Q 2 and Q 3 are all hydrogen atoms (1 )
The pyrimidine derivative according to the above item. (4) The pyrimidine derivative according to item (1), wherein in formula (1), n1 is 1 and n2 is 0. (5) In the general formula (1), (1), wherein n 1 is 0, n 2 is 1, Za and Zb are each a single bond, and Zc is —COO— or —CF 2 O—. The pyrimidine derivative according to the above. (6) In the general formula (1), n1 is 0, n2 is 1, Za and Zc are both single bonds, Zb is -COO- or -CF 2 O-(1) to item The pyrimidine derivative according to the above. (7) The pyrimidine derivative according to the item (1), wherein n1 + n2 = 2 in the general formula (1). (8) In the general formula (1), R is an alkyl group in which one or more hydrogen atoms in the group have been substituted with fluorine.
The pyrimidine derivative according to the above item. (9) A liquid crystal composition comprising at least one pyrimidine derivative according to any one of (1) to (8). (10) As a first component, at least one compound according to any one of (1) to (8) is contained,
As the second component, general formulas (2), (3) and (4)
【0011】[0011]
【化7】 Embedded image
【0012】(各式中、R3、Y1、L1、L2、Z1およ
びZ2は各式間で同一または互いに異なっていてもよ
く、R3は炭素数1〜10のアルキル基であり、このア
ルキル基中の相隣接しない一つ以上のメチレン基は酸素
原子または−CH=CH−で置換されていてもよく、ま
たこの基中の任意の水素原子はフッ素原子で置換されて
もよく;Y1はフッ素原子、塩素原子、−OCF3、−O
CF2H、−CF3、−CF2H、−CFH2、−OCF2
CF2H、または−OCF2CFHCF3を示し;L1およ
びL2は各々独立して水素原子またはフッ素原子を示
し;Z1およびZ2は各々独立して−CH2CH2−、−C
H2CH2CH2CH2−、−COO−、−CF2O−、−
OCF2−、−CH=CH−、または単結合を示し;環
Bはトランスー1,4−シクロヘキシレン、1,3−ジ
オキサン−2,5−ジイル、または水素原子がフッ素原
子で置換されてもよい1,4−フェニレンを示し;環C
はトランスー1,4−シクロヘキシレン、または水素原
子がフッ素原子で置換されてもよい1,4−フェニレン
を示し;また、これらの化合物を構成する各原子はその
同位体で置換されていてもよい。)からなる化合物群か
ら選択される化合物を少なくとも1種類含有することを
特徴とする液晶組成物。 (11) 第一成分として、(1)項から(8)項のい
ずれか1項に記載の化合物を少なくとも1種類含有し、
第二成分として、一般式(5)および(6)(In each formula, R 3 , Y 1 , L 1 , L 2 , Z 1 and Z 2 may be the same or different among the formulas, and R 3 is an alkyl group having 1 to 10 carbon atoms. Wherein one or more non-adjacent methylene groups in the alkyl group may be substituted with an oxygen atom or -CH = CH-, and any hydrogen atom in the group may be substituted with a fluorine atom. Y 1 is a fluorine atom, a chlorine atom, —OCF 3 , —O
CF 2 H, -CF 3, -CF 2 H, -CFH 2, -OCF 2
CF 2 H, or show the -OCF 2 CFHCF 3; L 1 and L 2 represents a hydrogen atom or a fluorine atom each independently; Z 1 and Z 2 are -CH 2 each independently CH 2 -, - C
H 2 CH 2 CH 2 CH 2 -, - COO -, - CF 2 O -, -
OCF 2 —, —CH = CH— or a single bond; ring B is trans-1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, or a compound in which a hydrogen atom is substituted by a fluorine atom. Shows good 1,4-phenylene; ring C
Represents trans-1,4-cyclohexylene or 1,4-phenylene in which a hydrogen atom may be substituted by a fluorine atom; and each atom constituting these compounds may be substituted by its isotope . A) a liquid crystal composition comprising at least one compound selected from the group consisting of: (11) As a first component, it contains at least one compound according to any one of (1) to (8),
As the second component, general formulas (5) and (6)
【0013】[0013]
【化8】 Embedded image
【0014】(各式中、R4およびR5は各々独立して炭
素数1〜10のアルキル基を示すが、該アルキル基中の
相隣接しない一つ以上のメチレン基は酸素原子または−
CH=CH−で置換されていてもよく、またこの基中の
水素原子はフッ素原子で置換されてもよく;Y2は−C
N、または−C≡C−CNを示し;環Eはトランスー
1,4−シクロヘキシレン、1,4−フェニレン、1,
3−ジオキサン−2,5−ジイル、またはピリミジン−
2,5−ジイルを示し;環Gはトランスー1,4−シク
ロヘキシレン、ピリミジン−2,5−ジイル、または水
素原子がフッ素原子で置換されていてもよい1,4−フ
ェニレンを示し;環Hはトランスー1,4−シクロヘキ
シレンまたは1,4−フェニレンを示し、Z3は−CH2
CH2−、−COO−または単結合を示し;L3、L4お
よびL5は各々独立して水素原子またはフッ素原子を示
し;b、cおよびdは各々独立して0または1であり;
また、これらの化合物を構成する各元素はその同位体で
置換されていてもよい。)からなる化合物群から選択さ
れる化合物を少なくとも1種類含有することを特徴とす
る液晶組成物。 (12) 第一成分として、(1)項から(8)項のい
ずれか1項に記載の化合物を少なくとも1種類含有し、
第二成分として、上記一般式(2)、(3)および
(4)からなる化合物群から選択される化合物を少なく
とも1種類含有し、第三成分として、一般式(7)、
(8)および(9)(In each formula, R 4 and R 5 each independently represent an alkyl group having 1 to 10 carbon atoms, and one or more non-adjacent methylene groups in the alkyl group are an oxygen atom or-
CH = CH- may be substituted with, also hydrogen atoms in the group may be substituted with a fluorine atom; Y 2 is -C
N represents —C≡C—CN; ring E is trans-1,4-cyclohexylene, 1,4-phenylene, 1,
3-dioxane-2,5-diyl or pyrimidine-
Ring G represents trans-1,4-cyclohexylene, pyrimidine-2,5-diyl, or 1,4-phenylene in which a hydrogen atom may be substituted by a fluorine atom; Represents trans-1,4-cyclohexylene or 1,4-phenylene, and Z 3 represents —CH 2
CH 2 -, - COO- or a single bond; L 3, L 4 and L 5 each independently represents a hydrogen atom or a fluorine atom; b, c and d each independently is 0 or 1;
In addition, each element constituting these compounds may be substituted with its isotope. A) a liquid crystal composition comprising at least one compound selected from the group consisting of: (12) As a first component, at least one compound according to any one of (1) to (8) is contained,
The second component contains at least one compound selected from the compound group consisting of the general formulas (2), (3) and (4), and the third component has a general formula (7)
(8) and (9)
【0015】[0015]
【化9】 Embedded image
【0016】(各式中、R6、R7、I、JおよびKは各
式間で同一または互いに異なっていてもよく、R6およ
びR7は各々独立して炭素数1〜10のアルキル基を示
し、このアルキル基中の相隣接しない一つ以上のメチレ
ン基は酸素原子または−CH=CH−で置換されていて
もよく、またこの基中の任意の水素原子はフッ素原子で
置換されてもよく;環I、環Jおよび環Kは各々独立し
て、トランスー1,4−シクロヘキシレン、ピリミジン
−2,5−ジイル、または水素原子がフッ素原子で置換
されてもよい1,4−フェニレンを示し;Z4およびZ5
は各々独立して、−C≡C−、−COO−、−CH2C
H2−、−CH=CH−または単結合を示し;また、こ
れらの化合物を構成する各原子はその同位体で置換され
ていてもよい。)からなる化合物群から選択される化合
物を少なくとも1種類含有することを特徴とする液晶組
成物。 (13) 第一成分として、(1)項から(8)項のい
ずれか1項に記載の化合物を少なくとも1種類含有し、
第二成分として、上記一般式(5)および(6)からな
る化合物群から選択される化合物を少なくとも1種類含
有し、第三成分として、上記一般式(7)、(8)およ
び(9)からなる化合物群から選択される化合物を少な
くとも1種類含有することを特徴とする液晶組成物。 (14) 第一成分として、(1)項から(8)項のい
ずれか1項に記載の化合物を少なくとも1種類含有し、
第二成分の一部分として、上記一般式(2)、(3)お
よび(4)からなる化合物群から選択される化合物を少
なくとも1種類含有し、第二成分の他の部分として上記
一般式(5)および(6)からなる化合物群から選択さ
れる化合物を少なくとも1種類含有し、第三成分とし
て、一般式(7)、(8)および(9)からなる化合物
群から選択される化合物を少なくとも1種類含有するこ
とを特徴とする液晶組成物。 (15) (9)項から(14)項のいずれか1項に記
載の液晶組成物に、さらに1種類以上の光学活性化合物
を含有することを特徴とする(9)項から(14)項の
いずれか1項に記載の液晶組成物。 (16) (9)項から(15)項のいずれか1項に記
載の液晶組成物を用いて構成した液晶表示素子。(In each formula, R 6 , R 7 , I, J and K may be the same or different between each formula, and R 6 and R 7 are each independently an alkyl having 1 to 10 carbon atoms. One or more non-adjacent methylene groups in the alkyl group may be substituted with an oxygen atom or -CH = CH-, and any hydrogen atom in the group may be substituted with a fluorine atom. Ring I, ring J and ring K are each independently trans-1,4-cyclohexylene, pyrimidine-2,5-diyl, or 1,4-, in which a hydrogen atom may be replaced by a fluorine atom. Represents phenylene; Z 4 and Z 5
Each independently, -C≡C -, - COO -, - CH 2 C
H 2 —, —CH = CH— or a single bond; and each atom constituting these compounds may be substituted with its isotope. A) a liquid crystal composition comprising at least one compound selected from the group consisting of: (13) As a first component, at least one compound according to any one of (1) to (8) is contained,
As the second component, at least one compound selected from the compound group consisting of the general formulas (5) and (6) is contained, and as the third component, the general formulas (7), (8) and (9) are included. A liquid crystal composition comprising at least one compound selected from the group consisting of: (14) As a first component, it contains at least one compound according to any one of (1) to (8),
As a part of the second component, at least one compound selected from the compound group consisting of the general formulas (2), (3), and (4) is contained, and as another part of the second component, the general formula (5) ) And at least one compound selected from the compound group consisting of (6), and as a third component, at least a compound selected from the compound group consisting of general formulas (7), (8) and (9) A liquid crystal composition comprising one type. (15) The liquid crystal composition according to any one of the above items (9) to (14), further comprising one or more optically active compounds. The liquid crystal composition according to any one of the above. (16) A liquid crystal display device comprising the liquid crystal composition according to any one of the above items (9) to (15).
【0017】[0017]
【発明の実施の形態】本発明の一般式(1)で示される
化合物は、分子末端は水素原子あるいは含ハロゲン電子
吸引基が置換したフェニレン基であり、かつこの環とピ
リミジン環以外に少なくとも1個のフッ素原子で置換さ
れた1,4−フェニレン基を有し、ピリミジン環を含め
て3個または4個の芳香族環を有する液晶性化合物であ
る。このような構造により、比較的高い電圧保持率、大
きなΔn、および大きなΔεを有し、かつ他の液晶性化
合物との低温相溶性に優れるものとなる。例えば、本発
明に属する化合物(No.17)は化合物(10)とア
ルキル鎖を同じくするが、以下のように特異的に大きな
Δεと良好な低温相溶性を有する。化合物(10)の物
性値は前述の通りであるが、実施例2に示すとおり本発
明化合物(No.17)のN−I転移点は48.4℃で
あるにも関わらずΔεは驚くべきことに31.0であ
る。実施例6および7に示すとおり、既存のフッ素置換
された液晶性化合物からなる液晶組成物に溶解した場
合、−20℃で30日間保存しても結晶の発生しない濃
度は、化合物(10)が5%未満であるのに対し、化合
物(No.17)は15%以上であり、本発明の化合物
が優れた低温相溶性を有することがわかる。実施例4お
よび5で示すように、化合物(10)の電圧保持率は2
5℃で97.5%、100℃で92.9%であるのに対
し、化合物(No.17)は25℃で97.5%、10
0℃で93.2%とほぼ同等の値を示す。一般式(1)
で表される本発明の化合物の中には、形式上WO94/
26840号、DE4445224号、及び特表平4−
503818号のクレームに包含されるものがある。し
かし、これら先行文献の中には本発明の化合物に関する
具体な記述や物性を示すデータを見いだすことはできな
い。さらに、本発明の化合物が上述の優れた特性を示す
ことを予見させるような記述もない。BEST MODE FOR CARRYING OUT THE INVENTION The compound represented by the general formula (1) of the present invention has a phenylene group substituted with a hydrogen atom or a halogen-containing electron-withdrawing group at the molecular terminal, and at least one ring other than this ring and a pyrimidine ring. It is a liquid crystal compound having a 1,4-phenylene group substituted with two fluorine atoms and having three or four aromatic rings including a pyrimidine ring. Such a structure has a relatively high voltage holding ratio, a large Δn, and a large Δε, and has excellent low-temperature compatibility with other liquid crystal compounds. For example, the compound (No. 17) belonging to the present invention has the same alkyl chain as the compound (10), but has specifically large Δε and good low-temperature compatibility as described below. Although the physical properties of compound (10) were as described above, Δε was surprising despite the fact that compound (No. 17) of the present invention had an NI transition point of 48.4 ° C. as shown in Example 2. In particular, it is 31.0. As shown in Examples 6 and 7, when dissolved in an existing liquid crystal composition comprising a fluorine-substituted liquid crystal compound, the concentration at which no crystal was generated even after storage at −20 ° C. for 30 days was as follows: In contrast to less than 5%, the content of the compound (No. 17) is 15% or more, indicating that the compound of the present invention has excellent low-temperature compatibility. As shown in Examples 4 and 5, the voltage holding ratio of compound (10) was 2
97.5% at 5 ° C and 92.9% at 100 ° C, whereas the compound (No. 17) has 97.5% and 107.5% at 25 ° C.
It shows almost the same value as 93.2% at 0 ° C. General formula (1)
Some of the compounds of the present invention represented by the formula WO94 /
No. 26840, DE44445224 and Tokuhei Hei 4-
Some are included in the claims of 503818. However, no specific description or data showing physical properties of the compound of the present invention can be found in these prior art documents. Furthermore, there is no description which predicts that the compound of the present invention exhibits the above-mentioned excellent properties.
【0018】ここで本発明の化合物をさらに詳しく説明
する。ただし、化合物を構成する元素がその同位体で置
換されたものについては言及しないが、同位体で置換さ
れた化合物も以下の説明で示す特性と何ら変わらない。
一般式(1)において、Rは水素原子、または、いずれ
も基中の1個以上の水素原子がハロゲン原子で置換され
ていてもよい炭素数1〜20のアルキル基、アルケニル
基、アルコキシ基、またはアルコキシアルキル基を示す
が、これらの基は低い粘性と高いN−I転移点のバラン
スという観点からみて、その炭素数は1〜7が好まし
く、2〜5がさらに好ましい。また、Rがアルキル基で
ある化合物は、Rがハロゲン置換アルキル基であるもの
に比べ粘性とN−I転移点のバランスに優れるが、他の
液晶性化合物との低温相溶性はハロゲン置換アルキル基
が優れる。Rがハロゲン置換アルキル基である化合物で
は、Rは末端の炭素にフッ素原子が1個置換したもの
が、粘性とN−I転移点のバランスに優れる。Rがアル
コキシ基またはアルコキシアルキル基である化合物は、
良好な低温相溶性を示す。Rがアルケニル基である化合
物は、Rがアルキル基であるものに比べ、電圧保持率は
劣るが、N−I転移点と粘性のバランスに優れる。一般
式(1)において、n1およびn2はそれぞれに独立して
0、1または2であり、n1とn2の和は1または2であ
る。n1とn2の和が1である化合物は低粘性であり、n
1とn2の和が2である化合物は高いN−I転移点を有す
る。連結基Za、ZbおよびZcはそれぞれに独立して
単結合、−COO−、−CH2CH2−、−CH2CH2C
H2CH2−、または−CF2O−を示すが、それぞれの
特徴を示すと次のようになる。連結基Za、Zbおよび
Zcがすべて単結合である化合物は比較的高いN−I転
移点を有し、低粘性であり、かつ他の液晶化合物あるい
は液晶組成物との相溶性に優れ、化学的、電気的にも安
定である。連結基Za、ZbおよびZcの少なくとも1
個が−CH2CH2−である化合物は、Za、Zbおよび
Zcがすべて単結合であるものに比べてN−I転移点は
やや低いものの、他の液晶性化合物との低温相溶性によ
り優れる。連結基Za、ZbおよびZcの少なくとも1
個が−COO−である化合物は、Za、ZbおよびZc
がすべて単結合であるものに比べて、電圧保持率はやや
劣るが大きなΔεを有する。連結基Za、ZbおよびZ
cの少なくとも1個が−CH2CH2CH2CH2−である
化合物は、連結基Za、ZbおよびZcがすべて単結合
であるものに比べて、粘性がやや高いが相溶性はさらに
優れる。連結基Za、ZbおよびZcの少なくとも1個
が−CF2O−である化合物は、連結基Za、Zbおよ
びZcがすべて単結合であるものに比べて、N−I転移
点は低いものの、低粘性で、大きなΔεを有し、化学的
にも電気的にも安定である。Now, the compounds of the present invention will be described in more detail. However, no mention is made of a compound in which an element constituting the compound is substituted with an isotope, but the compound substituted with an isotope has no difference from the characteristics shown in the following description.
In the general formula (1), R is a hydrogen atom, or an alkyl group, alkenyl group, alkoxy group having 1 to 20 carbon atoms, in which at least one hydrogen atom in the group may be substituted with a halogen atom, Or an alkoxyalkyl group, from the viewpoint of the balance between low viscosity and high NI transition point, these groups preferably have 1 to 7 carbon atoms, and more preferably 2 to 5 carbon atoms. Compounds in which R is an alkyl group have a better balance of viscosity and NI transition point than compounds in which R is a halogen-substituted alkyl group, but have low-temperature compatibility with other liquid crystal compounds due to the halogen-substituted alkyl group. Is excellent. In a compound in which R is a halogen-substituted alkyl group, R in which one terminal fluorine atom is substituted on the terminal carbon is excellent in balance between viscosity and NI transition point. A compound wherein R is an alkoxy group or an alkoxyalkyl group is
Shows good low-temperature compatibility. Compounds in which R is an alkenyl group have a lower voltage holding ratio than compounds in which R is an alkyl group, but have an excellent balance between the NI transition point and the viscosity. In the general formula (1), n1 and n2 are each independently 0, 1 or 2, and the sum of n1 and n2 is 1 or 2. A compound in which the sum of n1 and n2 is 1 has low viscosity and n
Compounds in which the sum of 1 and n2 is 2 have a high NI transition point. Linking groups Za, Zb and Zc are independently a single bond, respectively, -COO -, - CH 2 CH 2 -, - CH 2 CH 2 C
H 2 CH 2 — or —CF 2 O— is shown, and their characteristics are as follows. Compounds in which the linking groups Za, Zb and Zc are all single bonds have a relatively high NI transition point, low viscosity, excellent compatibility with other liquid crystal compounds or liquid crystal compositions, and chemical It is electrically stable. At least one of linking groups Za, Zb and Zc
Compounds having —CH 2 CH 2 — are slightly lower in NI transition point than those in which Za, Zb and Zc are all single bonds, but are more excellent in low-temperature compatibility with other liquid crystal compounds. . At least one of linking groups Za, Zb and Zc
Compounds represented by —COO— are Za, Zb and Zc
Are slightly inferior to those in which all are single bonds, but have a large Δε. Linking groups Za, Zb and Z
at least one is -CH 2 CH 2 CH 2 CH 2 of c - Compounds that are linking groups Za, Zb and Zc are compared to all single bonds, slightly high but compatibility viscosity further excellent. Linking groups Za, Compound least one is -CF 2 O-Zb, and Zc are linking groups Za, Zb and Zc are compared to all single bonds, although N-I transition point is low, low It is viscous, has a large Δε, and is chemically and electrically stable.
【0019】末端置換基Yについて、好ましい構造と、
その置換基を有する化合物の特徴を次に示す。YがFで
ある化合物は比較的大きなΔε有し、低粘性であり、他
の液晶化合物あるいは液晶組成物との相溶性に優れる。
Yが−CF3である化合物は非常に大きなΔεを有す
る。Yが−OCF3または−OCF2Hである化合物は低
粘性である。Y=Cl、−OCF2CF2H、または−O
CF2CFHCF3である化合物は大きなΔnと、高い透
明点を有する。Yが−OCH2CF2H、−OCH2C
F3、または−OCFHCF3である化合物は高いN−I
転移点を有し、比較的低粘性である。上記以外でYとし
て好ましい置換基は、−CF2H、−CF2Cl、−CH
2CF3、−CH2CH2F、−CH2CH2CH2F、−C
H2CH2CH2CH2F、−OCFH2、−OCF2Cl、
−OCF2CF3、−OCF2CF2CF3がある。1,4
−フェニレン基への置換基Q1〜Q7はそれぞれに独立し
て水素原子、ハロゲン原子あるいはメチル基を示すが、
ハロゲン原子およびメチル基の数がより多い化合物ほど
他の液晶性化合物あるいは液晶組成物との相溶性に優
れ、水素原子の数がより多い化合物ほど高いN−I転移
点を有する。Q2、Q5およびQ6の位置にハロゲン原子
の数が多い化合物ほど大きなΔεを有する。一般式
(1)で表される本発明の化合物はいずれも比較的高い
電圧保持率を有すると共に、その部分構造によって上記
のような特長を有するが、なかでも一般式(1−A)〜
(1−R)で表される化合物がな好ましい特性を有す
る。For the terminal substituent Y, a preferred structure:
The characteristics of the compound having the substituent are shown below. The compound in which Y is F has a relatively large Δε, has a low viscosity, and has excellent compatibility with other liquid crystal compounds or liquid crystal compositions.
Compound Y is -CF 3 has a very large [Delta] [epsilon]. Y is -OCF 3 or -OCF 2 H compounds are low viscosity. Y = Cl, -OCF 2 CF 2 H or -O,
The compound that is CF 2 CFHCF 3 has a large Δn and a high clearing point. Y is -OCH 2 CF 2 H, -OCH 2 C
Compounds that are F 3 or —OCFHCF 3 have high NI
It has a transition point and relatively low viscosity. Preferred substituents as Y except the above, -CF 2 H, -CF 2 Cl , -CH
2 CF 3, -CH 2 CH 2 F, -CH 2 CH 2 CH 2 F, -C
H 2 CH 2 CH 2 CH 2 F, -OCFH 2, -OCF 2 Cl,
—OCF 2 CF 3 and —OCF 2 CF 2 CF 3 . 1,4
-The substituents Q 1 to Q 7 to the phenylene group each independently represent a hydrogen atom, a halogen atom or a methyl group,
A compound having a larger number of halogen atoms and methyl groups is more compatible with another liquid crystal compound or a liquid crystal composition, and a compound having a larger number of hydrogen atoms has a higher NI transition point. A compound having a larger number of halogen atoms at the positions of Q 2 , Q 5 and Q 6 has a larger Δε. All of the compounds of the present invention represented by the general formula (1) have a relatively high voltage holding ratio and the above-mentioned features depending on their partial structures.
The compound represented by (1-R) has some preferable characteristics.
【0020】[0020]
【化10】 Embedded image
【0021】[0021]
【化11】 Embedded image
【0022】(ただしR、Q5、Q6およびYは前述と同
様の意味を示す。) 一般式(1−A)〜(1−R)で表される化合物の特性
を説明する。一般式(1−E)、(1−F)、(1−
J)、(1−K)および(1−R)で表される化合物は
他の化合物と比べて電圧保持率に関しては若干劣るが、
なおかついずれもTFT型液晶表示素子への使用に耐え
られる程度の高い電圧保持率を有する。また、本発明の
化合物はいずれも大きなΔnを有するので、特にセル厚
が薄い液晶表示素子用の液晶材料として有用である。一
般式(1−A)および(1−B)で表される化合物は低
粘性であり、Δεが大きく、他の液晶性化合物との低温
相溶性も良好である。両者を比較すると、N−I転移点
は(1−A)が高く、Δεは(1−B)が大きく、粘度
は(1−A)が低い。一般式(1−C)および(1−
D)で表される化合物はΔεが大きく、特に他の液晶性
化合物との低温相溶性も良好である。両者を比較する
と、N−I転移点は(1−C)が高く、Δεは(1−
D)が大きく、粘度は(1−C)が低い。一般式(1−
E)、(1−F)、(1−G)および(1−H)で表さ
れる化合物は極めてΔεが大きいことが特長である。こ
れらを比較すると、N−I転移点は(1−E)および
(1−F)が高く、粘度は(1−G)および(1−H)
が低い。一般式(1−I)で表される化合物は他の液晶
性化合物との低温相溶性に優れる。一般式(1−J)、
(1−K)、(1−L)および(1−M)で表される化
合物は極めてΔεが大きいことが特長である。これらを
比較すると、N−I転移点は(1−J)および(1−
K)が高く、粘度は(1−L)および(1−M)が低
い。一般式(1−N)〜(1−R)で表される化合物は
非常に高い透明点を有するため、高温での表示可能な液
晶材料の構成成分として有用である。(However, R, Q 5 , Q 6 and Y have the same meanings as described above.) The characteristics of the compounds represented by formulas (1-A) to (1-R) will be described. General formulas (1-E), (1-F), (1-
The compounds represented by J), (1-K) and (1-R) are slightly inferior in voltage holding ratio to other compounds,
Each of them has a high voltage holding ratio enough to withstand use in a TFT type liquid crystal display device. Further, since the compounds of the present invention all have a large Δn, they are particularly useful as a liquid crystal material for a liquid crystal display device having a small cell thickness. The compounds represented by formulas (1-A) and (1-B) have low viscosity, large Δε, and good low-temperature compatibility with other liquid crystal compounds. Comparing both, the NI transition point has a high (1-A), Δε has a large (1-B), and the viscosity has a low (1-A). General formulas (1-C) and (1-C)
The compound represented by D) has a large Δε, and particularly has good low-temperature compatibility with other liquid crystal compounds. Comparing the two, the NI transition point is higher in (1-C) and Δε is (1-C).
D) is large and the viscosity is low (1-C). The general formula (1-
The compounds represented by E), (1-F), (1-G) and (1-H) are characterized by extremely large Δε. When these are compared, the NI transition points are higher in (1-E) and (1-F), and the viscosities are (1-G) and (1-H).
Is low. The compound represented by the general formula (1-I) has excellent low-temperature compatibility with other liquid crystal compounds. General formula (1-J),
The compounds represented by (1-K), (1-L) and (1-M) are characterized by extremely large Δε. When these are compared, the NI transition points are (1-J) and (1-J).
K) is high and the viscosity is low for (1-L) and (1-M). Since the compounds represented by the general formulas (1-N) to (1-R) have a very high clearing point, they are useful as components of a liquid crystal material that can be displayed at high temperatures.
【0023】本発明の化合物ほど電圧保持率が高くかつ
Δεが大きくかつΔnが大きな化合物はこれまでに例が
ない。本発明の化合物は、上記の特長を有するので特
に、高い電圧保持率が必要でありかつのセル厚の薄い液
晶表示素子の製造をより容易にするものである。本発明
の化合物は特にTFT用液晶組成物に好適な液晶性化合
物であるが、他の用途、例えばTN用液晶組成物、G・
Hモード用の液晶組成物、ポリマ−分散型液晶表示素子
用の液晶組成物、動的散乱モ−ド用の液晶組成物、ST
N用の液晶組成物、強誘電性液晶組成物、反強誘電性液
晶組成物、インプレーンスイッチング用の液晶組成物、
OCB(Optically Compensated Birefringence)モ
ード用の液晶組成物、R−OCBモード用の液晶組成
物、にも好適に活用できる。There is no compound which has a higher voltage holding ratio, a larger Δε and a larger Δn than the compound of the present invention. Since the compound of the present invention has the above-mentioned features, it particularly requires a high voltage holding ratio and facilitates the production of a liquid crystal display device having a small cell thickness. The compound of the present invention is a liquid crystal compound particularly suitable for a liquid crystal composition for TFT, but may be used for other purposes such as a liquid crystal composition for TN,
Liquid crystal composition for H mode, liquid crystal composition for polymer dispersion type liquid crystal display element, liquid crystal composition for dynamic scattering mode, ST
N liquid crystal composition, ferroelectric liquid crystal composition, antiferroelectric liquid crystal composition, liquid crystal composition for in-plane switching,
The liquid crystal composition for OCB (Optically Compensated Birefringence) mode and the liquid crystal composition for R-OCB mode can be suitably used.
【0024】一般式(1)で表される化合物は、公知の
有機合成化学的手法を適切に組み合わせ用いることによ
り製造できる。例えば第4版実験化学講座(丸善)およ
び特表平4−501272号に記載されている方法によ
って製造することができる。以下に代表的化合物の好ま
しい合成手順を示す。式(1−A)、(1−B)、(1
−O)で表される化合物の合成法。The compound represented by the general formula (1) can be produced by appropriately combining known organic synthetic chemistry techniques. For example, it can be produced by the method described in the fourth edition of Experimental Chemistry Course (Maruzen) and Japanese Patent Publication No. 4-501272. Preferred synthetic procedures for representative compounds are shown below. Formulas (1-A), (1-B), (1
-O).
【0025】[0025]
【化12】 Embedded image
【0026】式(11)で表される化合物を酸性条件下
で尿素と反応させ、得られた生成物にオキシ塩化リン等
の塩素化試薬を作用させて、式(13)で表される化合
物が得られる。化合物(14)とマグネシウムとから調
製されるグリニヤール試薬(15)をNiCl2(dp
pp)の存在下で式(13)で表される化合物に作用さ
せて式(16)で表される化合物が得られる。化合物
(16)をブチルリチウム等のリチオ化試薬でリチオ化
し、このリチオ化物に塩化亜鉛、Pd(0)および化合
物(17)をこの順に作用させて式(18)で表される
化合物が得られる。この方法はJ.Org.Chem.,42,1821(19
77)に記載されている方法を利用したものである。また
J.Chem.Soc.Perkin Trans.2,2041(1989)に記載の方法
も利用できる。式(18)は式(1−A)、式(1−
B)および式(1−O)を包含する。The compound represented by the formula (13) is reacted with urea under acidic conditions, and the resulting product is reacted with a chlorinating reagent such as phosphorus oxychloride to give the compound represented by the formula (13) Is obtained. Grignard reagent (15) prepared from compound (14) and magnesium was converted to NiCl 2 (dp
By acting on a compound represented by the formula (13) in the presence of (pp), a compound represented by the formula (16) is obtained. The compound (16) is lithiated with a lithiating reagent such as butyllithium, and zinc chloride, Pd (0) and the compound (17) are acted on the lithiated product in this order to obtain a compound represented by the formula (18). . This method is described in J. Org. Chem., 42 , 1821 (19.
77). Also
The method described in J. Chem. Soc. Perkin Trans. 2, 2041 (1989) can also be used. The expression (18) is obtained by the expression (1-A) and the expression (1-
B) and Formula (1-O).
【0027】式(1−C)、式(1−D)および式(1
−P)で表される化合物の合成法。Equations (1-C), (1-D) and (1
A method for synthesizing a compound represented by -P).
【0028】[0028]
【化13】 Embedded image
【0029】化合物(14)に代えて化合物(17)を
用いる以外は、上記の化合物(16)を得る工程と同様
にして、式(20)で表される化合物が得られる。式
(20)は式(1−C)、式(1−D)および式(1−
P)を包含する。式(1−E)および式(1−F)で表
される化合物の合成法。A compound represented by the formula (20) is obtained in the same manner as in the step of obtaining the compound (16) except that the compound (17) is used instead of the compound (14). Equation (20) is obtained by dividing equation (1-C), equation (1-D), and equation (1-
P). A method for synthesizing a compound represented by the formula (1-E) and the formula (1-F).
【0030】[0030]
【化14】 Embedded image
【0031】化合物(16)をブチルリチウム等のリチ
オ化試薬でリチオ化し、このリチオ化物に二酸化炭素を
作用させ、式(21)で表される化合物が得られる。ジ
シクロヘキシルカルボジイミドと4−(ジメチルアミ
ノ)ピリジンの存在下で、化合物(21)と式(22)
で表されるフェノール誘導体とを反応させて、式(2
3)で表される化合物が得られる。式(23)は式(1
−E)および式(1−F)を包含する。この方法は第4
版実験化学講座22巻46頁に記載された方法である。
式(1−G)および式(1−H)で表される化合物の合
成法。The compound (16) is lithiated with a lithiating reagent such as butyllithium and the like, and carbon dioxide is allowed to act on the lithiated compound to obtain a compound represented by the formula (21). In the presence of dicyclohexylcarbodiimide and 4- (dimethylamino) pyridine, compound (21) and a compound of formula (22)
By reacting with a phenol derivative represented by the formula (2)
The compound represented by 3) is obtained. Equation (23) is obtained by using equation (1).
-E) and formula (1-F). This method is the fourth
This is the method described in Edition Experimental Chemistry Course, Vol. 22, page 46.
A method for synthesizing compounds represented by the formula (1-G) and the formula (1-H).
【0032】[0032]
【化15】 Embedded image
【0033】化合物(23)にローソン試薬を作用させ
て、式(24)で表される化合物が得られる。化合物
(24)にジエチルアミノサルファートリフルオリド
(DAST)、あるいはフッ化水素酸のピリジン溶液等
のフッ素化試薬を作用させて、式(25)で表される化
合物が得られる。式(25)は式(1−G)および式
(1−H)を包含する。式(1−I)で表される化合物
の合成法。The compound represented by the formula (24) is obtained by allowing a Lawson reagent to act on the compound (23). The compound represented by the formula (25) is obtained by reacting the compound (24) with a fluorinating reagent such as diethylaminosulfur trifluoride (DAST) or a pyridine solution of hydrofluoric acid. Equation (25) includes equations (1-G) and (1-H). A method for synthesizing a compound represented by the formula (1-I).
【0034】[0034]
【化16】 Embedded image
【0035】化合物(14)に代えて化合物(26)を
用いる以外は、上記の化合物(18)を得る工程と同様
にして、式(28)で表される化合物が得られる。式
(28)は式(1−I)を包含する。式(1−J)およ
び式(1−K)で表される化合物の合成法。A compound represented by the formula (28) is obtained in the same manner as in the step for obtaining the compound (18) except that the compound (26) is used instead of the compound (14). Equation (28) includes equation (1-I). A method for synthesizing the compounds represented by the formulas (1-J) and (1-K).
【0036】[0036]
【化17】 Embedded image
【0037】化合物(16)に代えて化合物(13)を
用いる以外は、上記の化合物(21)を得る工程と同様
にして、式(29)で表される化合物を得ることができ
る。化合物(16)に代えて水酸基が保護されたフェノ
ール誘導体(30)を用いる以外は、上記の化合物(1
8)を得る工程と同様にして、式(31)で表される化
合物が得られる。化合物(31)を酸で処理することに
より式(32)で表される化合物が得られる。化合物
(21)に代えて化合物(29)を用い、化合物(2
2)に代えて化合物(32)を用いる以外は、前記の化
合物(23)を得る工程と同様にして、式(33)で表
される化合物が得られる。式(33)は式(1−J)お
よび式(1−K)を包含する。式(1−L)および式
(1−M)で表される化合物の合成法。A compound represented by the formula (29) can be obtained in the same manner as in the step of obtaining the compound (21) except that the compound (13) is used instead of the compound (16). Except that the phenol derivative (30) having a protected hydroxyl group is used instead of the compound (16), the compound (1)
The compound represented by the formula (31) is obtained in the same manner as in the step of obtaining 8). The compound represented by the formula (32) is obtained by treating the compound (31) with an acid. Compound (29) is used in place of compound (21), and compound (2)
A compound represented by the formula (33) is obtained in the same manner as in the step of obtaining the compound (23) except that the compound (32) is used instead of 2). Equation (33) includes equations (1-J) and (1-K). A method for synthesizing a compound represented by the formula (1-L) and the formula (1-M).
【0038】[0038]
【化18】 Embedded image
【0039】化合物(23)に代えて化合物(33)を
用いる以外は、上記の化合物(25)を得る工程と同様
にして、式(35)で表される化合物が得られる。式
(33)は式(1−L)および式(1−M)を包含す
る。式(1−N)で表される化合物の合成法。A compound represented by the formula (35) is obtained in the same manner as in the step for obtaining the compound (25) except that the compound (33) is used instead of the compound (23). Formula (33) includes formula (1-L) and formula (1-M). A method for synthesizing a compound represented by the formula (1-N).
【0040】[0040]
【化19】 Embedded image
【0041】化合物(17)に代えて化合物(14)を
用いる以外は、上記の化合物(18)を得る工程と同様
にして、式(36)で表される化合物が得られる。化合
物(16)に代えて化合物(36)を用る以外は、上記
の化合物(18)を得る工程と同様にして、式(37)
で表される化合物が得られる。式(37)は式(1−
N)を包含する。式(1−R)で表される化合物の合成
法。A compound represented by the formula (36) is obtained in the same manner as in the step for obtaining the compound (18) except that the compound (14) is used instead of the compound (17). A compound of the formula (37) described in the same manner as in the step of obtaining the compound (18), except that the compound (36) is used instead of the compound (16).
The compound represented by is obtained. Equation (37) is obtained by calculating equation (1-
N). A method for synthesizing a compound represented by the formula (1-R).
【0042】[0042]
【化20】 Embedded image
【0043】化合物(16)に代えて化合物(36)を
用いる以外は、上記の化合物(23)を得る工程と同様
にして、式(39)で表される化合物が得られる。式
(39)は式(1−R)を包含する。A compound represented by the formula (39) is obtained in the same manner as in the step for obtaining the compound (23) except that the compound (36) is used instead of the compound (16). Formula (39) includes Formula (1-R).
【0044】本発明の液晶組成物は一般式(1)で表さ
れる化合物の1種類以上を0.1〜99.9重量%の割
合で含有することが優良な特性を発現するために好まし
く、より好ましくはその割合は1〜50重量%、さらに
好ましくは3〜20重量%である。本発明で提供される
液晶組成物は、一般式(1)で表される化合物を少なく
とも一種類含有する第一成分に加え、一般式(2)〜
(9)で表される化合物群から液晶組成物の目的に応じ
て選択される化合物を混合して完成する。本発明の液晶
組成物に用いられる一般式(2)〜(4)で表される化
合物の好ましい例として以下の化合物を挙げることがで
きる。The liquid crystal composition of the present invention preferably contains one or more compounds represented by the general formula (1) at a ratio of 0.1 to 99.9% by weight in order to exhibit excellent characteristics. More preferably, the ratio is 1 to 50% by weight, further preferably 3 to 20% by weight. The liquid crystal composition provided by the present invention includes a first component containing at least one compound represented by the general formula (1),
Compounds selected from the compound group represented by (9) according to the purpose of the liquid crystal composition are mixed to complete the composition. Preferred examples of the compounds represented by formulas (2) to (4) used in the liquid crystal composition of the present invention include the following compounds.
【0045】[0045]
【化21】 Embedded image
【0046】[0046]
【化22】 Embedded image
【0047】[0047]
【化23】 Embedded image
【0048】[0048]
【化24】 Embedded image
【0049】[0049]
【化25】 Embedded image
【0050】[0050]
【化26】 Embedded image
【0051】[0051]
【化27】 Embedded image
【0052】[0052]
【化28】 Embedded image
【0053】[0053]
【化29】 Embedded image
【0054】(R3、Y1は前記と同一の意味を示す。) 一般式(2)〜(4)で表される化合物は誘電率異方性
値が正の化合物であり、熱的安定性や化学的安定性が優
れており、電圧保持率が高い(あるいは比抵抗値が大き
い)といった高信頼性が要求されるTFT用の液晶組成
物を調製する場合に、極めて有用な化合物である。TF
T用の液晶組成物を調製する場合、一般式(2)〜
(4)で表される化合物は液晶組成物の全重量に対して
1〜99重量%の範囲で使用できるが、好ましくは10
〜97重量%、より好ましくは40〜95重量%であ
る。また、その際に、さらに一般式式(7)〜(9)で
表される化合物を粘度調整の目的で含有してもよい。S
TN用またはTN用の液晶組成物を調製する場合にも、
一般式(2)〜(4)で表される化合物を使用できる。
本発明の液晶組成物に用いられる一般式(5)および
(6)で表される化合物の好ましい例として以下の化合
物を挙げることができる。(R3 and Y1 have the same meanings as described above.) The compounds represented by the general formulas (2) to (4) are compounds having a positive dielectric anisotropy value, and have thermal stability and This compound is extremely useful when preparing a liquid crystal composition for a TFT that requires high reliability such as excellent chemical stability and high voltage holding ratio (or high specific resistance value). TF
When preparing a liquid crystal composition for T, the general formula (2)
The compound represented by (4) can be used in a range of 1 to 99% by weight based on the total weight of the liquid crystal composition, but is preferably 10% by weight.
9797% by weight, more preferably 40-95% by weight. At that time, the compounds represented by the general formulas (7) to (9) may be further contained for the purpose of adjusting the viscosity. S
When preparing a liquid crystal composition for TN or TN,
Compounds represented by general formulas (2) to (4) can be used.
Preferred examples of the compounds represented by formulas (5) and (6) used in the liquid crystal composition of the present invention include the following compounds.
【0055】[0055]
【化30】 Embedded image
【0056】[0056]
【化31】 Embedded image
【0057】[0057]
【化32】 Embedded image
【0058】[0058]
【化33】 Embedded image
【0059】(式中、R4、R5、Y2は前記と同一の意
味を示す。) 一般式(5)および(6)で表される化合物は誘電率異
方性値が正でその値が大きく、特に液晶組成物のしきい
値電圧を小さくする目的で使用される。また、屈折率異
方性値の調整、透明点を高くする等のネマチックレンジ
を広げる目的にも使用される。さらに、STN用および
TN用の液晶組成物の電圧−透過率曲線の急峻性を改良
する目的にも使用される。一般式(5)および(6)で
表される化合物は、STN用およびTN用の液晶組成物
を調製する場合には、特に有用な化合物である。液晶組
成物中に一般式(5)および(6)で表される化合物の
量が増加すると、液晶組成物のしきい値電圧は小さくな
るが、粘度が上昇する。したがって、液晶組成物の粘度
が要求値を満足している限り、多量に使用した方が低電
圧で駆動できるので有利である。STN用またはTN用
の液晶組成物を調製する場合に、一般式(5)および
(6)で表される化合物は液晶組成物の全重量に対して
0.1〜99.9重量%の範囲で使用できるが、好まし
くは10〜97重量%、より好ましくは40〜95重量
%である。本発明の液晶組成物に用いられる一般式
(7)〜(9)で表される化合物の好ましい例として以
下の化合物を挙げることができる。(Wherein, R 4 , R 5 , and Y 2 have the same meanings as described above.) The compounds represented by the general formulas (5) and (6) have a positive dielectric anisotropy value and have a positive dielectric anisotropy value. It is used for the purpose of decreasing the threshold voltage of the liquid crystal composition, especially because of its large value. It is also used for the purpose of adjusting the value of the refractive index anisotropy and expanding the nematic range such as increasing the clearing point. Further, it is also used for the purpose of improving the steepness of the voltage-transmittance curve of the liquid crystal compositions for STN and TN. The compounds represented by the general formulas (5) and (6) are particularly useful when preparing liquid crystal compositions for STN and TN. When the amount of the compound represented by the general formulas (5) and (6) increases in the liquid crystal composition, the threshold voltage of the liquid crystal composition decreases, but the viscosity increases. Therefore, as long as the viscosity of the liquid crystal composition satisfies the required value, it is advantageous to use a large amount because the liquid crystal composition can be driven at a low voltage. When preparing a liquid crystal composition for STN or TN, the compounds represented by the general formulas (5) and (6) are in the range of 0.1 to 99.9% by weight based on the total weight of the liquid crystal composition. , But is preferably from 10 to 97% by weight, more preferably from 40 to 95% by weight. Preferred examples of the compounds represented by formulas (7) to (9) used in the liquid crystal composition of the present invention include the following compounds.
【0060】[0060]
【化34】 Embedded image
【0061】[0061]
【化35】 Embedded image
【0062】[0062]
【化36】 Embedded image
【0063】[0063]
【化37】 Embedded image
【0064】(R6およびR7は前記と同一の意味を示
す。) 一般式(7)〜(9)で表される化合物は、誘電率異方
性の絶対値が小さく、ゼロに近い化合物である。一般式
(7)の化合物は主として粘度調整または屈折率異方性
値の調整の目的で使用される。また、一般式(8)およ
び(9)で表される化合物は透明点を高くする等のネマ
チックレンジを広げる目的または屈折率異方性値の調整
の目的で使用される。液晶組成物中に一般式(7)〜
(9)で表される化合物の量が増加すると液晶組成物の
しきい値電圧が大きくなるが、粘度が小さくなる。した
がって、液晶組成物のしきい値電圧が要求値を満足して
いる限り、多量に使用することが望ましい。TFT用の
液晶組成物を調製する場合には、一般式(7)〜(9)
で表される化合物の使用量は40重量%以下が好まし
く、より好ましくは35重量%以下である。また、ST
N用またはTN用の液晶組成物を調製する場合には70
重量%以下が好ましく、より好ましくは60重量%以下
である。(R 6 and R 7 have the same meaning as described above.) The compounds represented by the general formulas (7) to (9) have a small absolute value of dielectric anisotropy and are close to zero. It is. The compound of the general formula (7) is mainly used for adjusting the viscosity or adjusting the refractive index anisotropy value. Further, the compounds represented by the general formulas (8) and (9) are used for the purpose of widening the nematic range such as increasing the clearing point or adjusting the refractive index anisotropy value. Formula (7)-
When the amount of the compound represented by (9) increases, the threshold voltage of the liquid crystal composition increases, but the viscosity decreases. Therefore, it is desirable to use a large amount as long as the threshold voltage of the liquid crystal composition satisfies the required value. When preparing a liquid crystal composition for a TFT, general formulas (7) to (9)
The amount of the compound represented by is preferably 40% by weight or less, more preferably 35% by weight or less. ST
When preparing a liquid crystal composition for N or TN, 70
% By weight or less, more preferably 60% by weight or less.
【0065】また、本発明では、OCBモード用液晶組
成物等の特別な場合を除き、通常、液晶組成物のらせん
構造を誘起して必要なねじれ角を調整し、逆ねじれ(re
verse twist)を防ぐ目的で、光学活性化合物を添加す
る。このような目的で公知のいずれの光学活性化合物も
使用できるが、好ましい例として以下の光学活性化合物
(Op−1)〜(Op−8)を挙げることができる。In the present invention, except for a special case such as a liquid crystal composition for an OCB mode, a helical structure of the liquid crystal composition is usually induced to adjust a necessary twist angle, and a reverse twist (reverse twist) is obtained.
For the purpose of preventing verse twist), an optically active compound is added. For this purpose, any known optically active compounds can be used. Preferred examples include the following optically active compounds (Op-1) to (Op-8).
【0066】[0066]
【化38】 Embedded image
【0067】本発明の液晶組成物は、通常、これらの光
学活性化合物を添加して、ねじれのピッチを調整する。
ねじれのピッチは、TFT用およびTN用の液晶組成物
であれば40〜200μmの範囲に調整するのが好まし
い。STN用の液晶組成物であれば6〜20μmの範囲
に調整するのが好ましい。また、双安定TN(Bistable
TN)モード用の液晶組成物の場合には、1.5〜4μ
mの範囲に調整するのが好ましい。また、ピッチの温度
依存性を調整する目的で、2種以上の光学活性化合物を
添加してもよい。In the liquid crystal composition of the present invention, these optically active compounds are usually added to adjust the twist pitch.
The twist pitch is preferably adjusted in the range of 40 to 200 μm for a liquid crystal composition for TFT and TN. In the case of a liquid crystal composition for STN, it is preferable to adjust the composition to a range of 6 to 20 μm. In addition, bistable TN (Bistable
TN) In the case of a liquid crystal composition for a mode, 1.5 to 4 μm
It is preferable to adjust to the range of m. Further, two or more optically active compounds may be added for the purpose of adjusting the temperature dependency of the pitch.
【0068】また、本発明の液晶組成物は、メロシアニ
ン系、スチリル系、アゾ系、アゾメチン系、アゾキシ
系、キノフタロン系、アントラキノン系、およびテトラ
ジン系等の二色性色素を添加してゲストホスト(GH)
モード用の液晶組成物としても使用できる。あるいは、
ネマチック液晶をマイクロカプセル化して作製したNC
APや液晶中に三次元網目状高分子を作製したポリマー
ネットワーク液晶表示素子(PNLCD)に代表される
ポリマー分散型液晶表示素子(PDLCD)用の液晶組
成物としても使用できる。その他、複屈折制御(EC
B)モードや動的散乱(DS)モード用の液晶組成物と
しても使用できる。The liquid crystal composition of the present invention is prepared by adding a dichroic dye such as merocyanine, styryl, azo, azomethine, azoxy, quinophthalone, anthraquinone, and tetrazine to the guest host ( GH)
It can also be used as a liquid crystal composition for a mode. Or,
NC made by encapsulating nematic liquid crystal
It can also be used as a liquid crystal composition for a polymer dispersed liquid crystal display (PDLCD) represented by a polymer network liquid crystal display (PNLCD) in which a three-dimensional network polymer is prepared in an AP or liquid crystal. In addition, birefringence control (EC
It can also be used as a liquid crystal composition for B) mode or dynamic scattering (DS) mode.
【0069】本発明の液晶組成物は、慣用な方法で調製
される。一般には、種々の成分を高い温度で互いに溶解
させる方法がとられている。本発明の液晶性化合物を含
有する液晶組成物の例として以下の組成物例(組成物例
1〜18)を示す。なお、各組成物例中において、化合
物は表1に示した取り決めに従い、左末端基、結合基、
環構造および右末端基の各部分を記号化して記載した。
本発明の化合物に付した化合物No.は後述の実施例中
に示されるそれと同一である。組成物例および実施例に
おいて、特に規定のない限り「%」は「重量%」を意味
する。また、組成物例の物性デ−タは、TNI(N−I転
移点または透明点:℃)、η(粘度:測定温度20.0
℃)、Δn(屈折率異方性値:測定温度25.0℃)、
Δε(誘電率異方性値:測定温度25.0℃)およびV
th(しきい値電圧:測定温度25.0℃)により示し
た。The liquid crystal composition of the present invention is prepared by a conventional method. Generally, a method of dissolving various components at a high temperature is used. The following composition examples (composition examples 1 to 18) are shown as examples of the liquid crystal composition containing the liquid crystal compound of the present invention. In each of the composition examples, the compound is represented by a left terminal group, a bonding group,
Each part of the ring structure and the right terminal group is symbolized and described.
Compound No. attached to the compound of the present invention. Is the same as that shown in the embodiment described later. In the composition examples and examples, “%” means “% by weight” unless otherwise specified. The physical property data of the composition examples are TNI (NI transition point or clearing point: ° C.), η (viscosity: measurement temperature 20.0 ° C.).
° C), Δn (refractive index anisotropy value: measuring temperature 25.0 ° C),
Δε (dielectric anisotropy value: measuring temperature 25.0 ° C.) and V
th (threshold voltage: measured temperature: 25.0 ° C.).
【0070】[0070]
【化39】 Embedded image
【0071】 組成物例1 5−PyB(F,F)B(F)−OCF3 (No.17) 14.0% 1V2−BEB(F,F)−C 5.0% 3−HB−C 25.0% 1−BTB−3 5.0% 2−BTB−1 10.0% 3−HH−4 11.0% 3−HHB−1 11.0% 3−HHB−3 9.0% 3−H2BTB−2 4.0% 3−HB(F)TB−2 6.0% TNI =76.7(℃) Δn =0.151 Δε =11.4 Vth =1.90(V) 上記組成物100重量部に光学活性化合物(OP−4)
を0.8部添加した組成物のピッチは10.5μmであ
った。Composition Example 1 5-PyB (F, F) B (F) -OCF3 (No. 17) 14.0% 1V2-BEB (F, F) -C 5.0% 3-HB-C25 1.0% 1-BTB-3 5.0% 2-BTB-1 10.0% 3-HH-4 11.0% 3-HHB-1 11.0% 3-HHB-3 9.0% 3- H2BTB-2 4.0% 3-HB (F) TB-2 6.0% TNI = 76.7 (° C.) Δn = 0.151 Δε = 11.4 Vth = 1.90 (V) The above composition 100 Optically active compound (OP-4) in parts by weight
Of the composition to which 0.8 part was added was 10.5 μm.
【0072】 組成物例2 5−PyB(F)B(F,F)−F (No.1) 5.0% 3−PyB(F,CL)B−CL (No.19) 5.0% 4−B(F,F)PyB(F)−OCF2CF2H (No.37) 5.0% 2O1−BEB(F)−C 5.0% 3O1−BEB(F)−C 15.0% 4O1−BEB(F)−C 13.0% 5O1−BEB(F)−C 13.0% 2−HHB(F)−C 15.0% 3−HB(F)TB−2 4.0% 3−HB(F)TB−3 4.0% 3−HB(F)TB−4 4.0% 3−HHB−1 8.0% 3−HHB−O1 4.0%Composition Example 2 5-PyB (F) B (F, F) -F (No. 1) 5.0% 3-PyB (F, CL) B-CL (No. 19) 5.0% 4-B (F, F) PyB (F) -OCF2CF2H (No. 37) 5.0% 2O1-BEB (F) -C 5.0% 3O1-BEB (F) -C 15.0% 4O1-BEB (F) -C 13.0% 5O1-BEB (F) -C 13.0% 2-HHB (F) -C 15.0% 3-HB (F) TB-2 4.0% 3-HB ( F) TB-3 4.0% 3-HB (F) TB-4 4.0% 3-HHB-1 8.0% 3-HHB-O1 4.0%
【0073】 組成物例3 3−B(F)B(F)PyB−F (No.135) 5.0% 5−PyB(F)EB(F,F)−F (No.41) 6.0% 3−BEB(F)−C 8.0% 3−HB−C 8.0% V−HB−C 8.0% 1V−HB−C 8.0% 3−HB−O2 3.0% 3−HH−2V 14.0% 3−HH−2V1 7.0% V2−HHB−1 15.0% 3−HHB−1 5.0% 3−HHEB−F 7.0% 3−H2BTB−2 6.0%Composition Example 3 3-B (F) B (F) PyB-F (No. 135) 5.0% 5-PyB (F) EB (F, F) -F (No. 41) 0% 3-BEB (F) -C 8.0% 3-HB-C 8.0% V-HB-C 8.0% 1V-HB-C 8.0% 3-HB-O2 3.0% 3-HH-2V 14.0% 3-HH-2V1 7.0% V2-HHB-1 15.0% 3-HHB-1 5.0% 3-HHEB-F 7.0% 3-H2BTB-2 6.0%
【0074】 組成物例4 4−BPyB(F,F)B(F)−F (No.142) 2.0% 7−B(F)PyB(F)−CF3 (No.26) 2.0% V2−HB−C 12.0% 1V2−HB−C 12.0% 3−HB−C 15.0% 3−H(1D,2D,3D)B−C 9.0% 3−HB(F)−C 5.0% 2−BTB−1 2.0% 3−HH−4 8.0% 3−HH−VFF 6.0% 2−H(1D,2D,3D)HB−C 3.0% 3−HHB−C 6.0% 3−HB(F)TB−2 8.0% 3−H2BTB−2 5.0% 3−H2BTB−3 5.0%Composition Example 4 4-BPyB (F, F) B (F) -F (No. 142) 2.0% 7-B (F) PyB (F) -CF3 (No. 26) 2.0 % V2-HB-C 12.0% 1V2-HB-C 12.0% 3-HB-C 15.0% 3-H (1D, 2D, 3D) BC 9.0% 3-HB (F ) -C 5.0% 2-BTB-1 2.0% 3-HH-4 8.0% 3-HH-VFF 6.0% 2-H (1D, 2D, 3D) HB-C 3.0 3-HHB-C 6.0% 3-HB (F) TB-2 8.0% 3-H2BTB-2 5.0% 3-H2BTB-3 5.0%
【0075】 組成物例5 4−HPyB(F)B(F)−F (No.150) 3.0% 2−PyB(F,F)CF2OB(F)−F (No.74) 2.0% 3−PyEB(F,F)B(F,F)−OCF3 (No.92) 2.0% 1−PyCF2OB(F)B−F (No.108) 2.0% 5−BEB(F)−C 5.0% V−HB−C 11.0% 5−PyB−C 6.0% 4−BB−3 11.0% 3−HH−2V 10.0% 5−HH−V 11.0% V−HHB−1 7.0% V2−HHB−1 15.0% 1V2−HBB−2 10.0% 3−HHEBH−3 5.0%Composition Example 5 4-HPyB (F) B (F) -F (No. 150) 3.0% 2-PyB (F, F) CF2OB (F) -F (No. 74) 2.0 % 3-PyEB (F, F) B (F, F) -OCF3 (No. 92) 2.0% 1-PyCF2OB (F) BF (No. 108) 2.0% 5-BEB (F) -C 5.0% V-HB-C 11.0% 5-PyB-C 6.0% 4-BB-3 11.0% 3-HH-2V 10.0% 5-HH-V 11.0 % V-HHB-1 7.0% V2-HHB-1 15.0% 1V2-HBB-2 10.0% 3-HHEBH-3 5.0%
【0076】 組成物例6 5−PyB(F,F)B(F,F)EB(F)−OCF2CFHCF3 (No.156) 4.0% 5−PyB(F,F)B(F,F)B(F)−CL (No.129) 4.0% 1V2−BEB(F,F)−C 8.0% 3−HB−C 10.0% V2V−HB−C 14.0% V2V−HH−3 19.0% 3−HB−O2 4.0% 3−HHB−1 10.0% 3−HHB−3 15.0% 3−HB(F)TB−2 4.0% 3−HB(F)TB−3 4.0% 3−H2BTB−2 4.0%Composition Example 6 5-PyB (F, F) B (F, F) EB (F) -OCF2CFHCF3 (No. 156) 4.0% 5-PyB (F, F) B (F, F) B (F) -CL (No. 129) 4.0% 1V2-BEB (F, F) -C 8.0% 3-HB-C 10.0% V2V-HB-C 14.0% V2V-HH -3 19.0% 3-HB-O2 4.0% 3-HHB-1 10.0% 3-HHB-3 15.0% 3-HB (F) TB-2 4.0% 3-HB ( F) TB-3 4.0% 3-H2BTB-2 4.0%
【0077】 組成物例7 F5−PyB(F,F)B(F)−F (No.10) 6.0% V2−HB−TC 10.0% 3−HB−TC 10.0% 3−HB−C 10.0% 5−HB−C 7.0% 5−BB−C 3.0% 2−BTB−1 10.0% 2−BTB−O1 5.0% 3−HH−4 5.0% 3−HHB−1 10.0% 3−HHB−3 11.0% 3−H2BTB−2 3.0% 5−BTB(F)TB−3 10.0%Composition Example 7 F5-PyB (F, F) B (F) -F (No. 10) 6.0% V2-HB-TC 10.0% 3-HB-TC 10.0% 3- HB-C 10.0% 5-HB-C 7.0% 5-BB-C 3.0% 2-BTB-1 10.0% 2-BTB-O1 5.0% 3-HH-4 0% 3-HHB-1 10.0% 3-HHB-3 11.0% 3-H2BTB-2 3.0% 5-BTB (F) TB-3 10.0%
【0078】 組成物例8 5−PyB(F,F)B(F)−OCF3 (No.17) 8.0% 1V2−BEB(F,F)−C 6.0% 3−HB−C 18.0% 2−BTB−1 10.0% 5−HH−VFF 30.0% 1−BHH−VFF 8.0% 1−BHH−2VFF 11.0% 3−H2BTB−2 5.0% 3−HHB−1 4.0% TNI =73.1(℃) Δn =0.124 Δε =9.0 Vth =1.73(V)Composition Example 8 5-PyB (F, F) B (F) -OCF3 (No. 17) 8.0% 1V2-BEB (F, F) -C 6.0% 3-HB-C 18 0.0% 2-BTB-1 10.0% 5-HH-VFF 30.0% 1-BHH-VFF 8.0% 1-BHH-2VFF 11.0% 3-H2BTB-2 5.0% 3- HHB-1 4.0% TNI = 73.1 (° C) Δn = 0.124 Δε = 9.0 Vth = 1.73 (V)
【0079】 組成物例9 5−PyB(F,F)B(F)−OCF3 (No.17) 13.0% 2−HHB(F)−F 17.0% 3−HHB(F)−F 17.0% 5−HHB(F)−F 16.0% 2−H2HB(F)−F 10.0% 3−H2HB(F)−F 5.0% 5−H2HB(F)−F 10.0% 2−HBB(F)−F 6.0% 3−HBB(F)−F 6.0% TNI =94.5(℃) Δn =0.098 Δε =8.1 Vth =1.82(V) 上記の組成物100重量部に光学活性化合物(OP−
8)を0.3重量部添加した組成物のピッチは79.0
μmであった。Composition Example 9 5-PyB (F, F) B (F) -OCF3 (No. 17) 13.0% 2-HHB (F) -F 17.0% 3-HHB (F) -F 17.0% 5-HHB (F) -F 16.0% 2-H2HB (F) -F 10.0% 3-H2HB (F) -F 5.0% 5-H2HB (F) -F 0% 2-HBB (F) -F 6.0% 3-HBB (F) -F 6.0% TNI = 94.5 (° C) Δn = 0.098 Δε = 8.1 Vth = 1.82 ( V) 100 parts by weight of the above composition was added to an optically active compound (OP-
The pitch of the composition containing 0.3 part by weight of 8) was 79.0.
μm.
【0080】 組成物例10 5−PyB(F)B(F,F)−F (No.1) 4.0% 3−HB−CL 10.0% 5−HB−CL 4.0% 7−HB−CL 4.0% 1O1−HH−5 5.0% 2−HBB(F)−F 8.0% 3−HBB(F)−F 8.0% 5−HBB(F)−F 14.0% 4−HHB−CL 8.0% 5−HHB−CL 8.0% 3−H2HB(F)−CL 4.0% 3−HBB(F,F)−F 10.0% 5−H2BB(F,F)−F 9.0% 3−HB(F)VB−2 4.0%Composition Example 10 5-PyB (F) B (F, F) -F (No. 1) 4.0% 3-HB-CL 10.0% 5-HB-CL 4.0% 7- HB-CL 4.0% 1O1-HH-5 5.0% 2-HBB (F) -F 8.0% 3-HBB (F) -F 8.0% 5-HBB (F) -F 14. 0% 4-HHB-CL 8.0% 5-HHB-CL 8.0% 3-H2HB (F) -CL 4.0% 3-HBB (F, F) -F 10.0% 5-H2BB ( F, F) -F 9.0% 3-HB (F) VB-2 4.0%
【0081】 組成物例11 3−PyB(F,CL)B−CL (No.19) 5.0% 4−B(F,F)PyB(F)−OCF2CF2H (No.37) 5.0% 7−B(F)PyB(F)−CF3 (No.26) 5.0% 5−PyB(F)EB(F,F)−F (No.41 5.0% 3−HHB(F,F)−F 9.0% 3−H2HB(F,F)−F 8.0% 4−H2HB(F,F)−F 8.0% 5−H2HB(F,F)−F 8.0% 3−HBB(F,F)−F 21.0% 3−H2BB(F,F)−F 10.0% 5−HHBB(F,F)−F 3.0% 5−HHEBB−F 2.0% 3−HH2BB(F,F)−F 3.0% 1O1−HBBH−4 4.0% 1O1−HBBH−5 4.0%Composition Example 11 3-PyB (F, CL) B-CL (No. 19) 5.0% 4-B (F, F) PyB (F) -OCF2CF2H (No. 37) 5.0% 7-B (F) PyB (F) -CF3 (No. 26) 5.0% 5-PyB (F) EB (F, F) -F (No. 41 5.0% 3-HHB (F, F) ) -F 9.0% 3-H2HB (F, F) -F 8.0% 4-H2HB (F, F) -F 8.0% 5-H2HB (F, F) -F 8.0% 3 -HBB (F, F) -F 21.0% 3-H2BB (F, F) -F 10.0% 5-HHBB (F, F) -F 3.0% 5-HHEBB-F 2.0% 3-HH2BB (F, F) -F 3.0% 1O1-HBBH-4 4.0% 1O1-HBBH-5 4.0%
【0082】 組成物例12 2−PyB(F,F)CF2OB(F)−F (No.74) 5.0% 3−PyEB(F,F)B(F,F)−OCF3 (No.92) 4.0% 1−PyCF2OB(F)B−F (No.10) 4.0% 5−PyB(F,F)B(F,F)B(F)−CL (No.129) 4.0% 3−B(F)B(F)PyB−F (No.135) 4.0% 5−HB−F 12.0% 6−HB−F 9.0% 7−HB−F 7.0% 5−HHB−OCF3 5.0% 3−HH2B−OCF3 4.0% 5−HH2B−OCF3 4.0% 3−HHB(F,F)−OCF3 5.0% 3−HBB(F)−F 10.0% 5−HBB(F)−F 10.0% 3−HH2B(F)−F 3.0% 3−HB(F)BH−3 3.0% 5−HBBH−3 3.0% 3−HHB(F,F)−OCF2H 4.0%Composition Example 12 2-PyB (F, F) CF2OB (F) -F (No. 74) 5.0% 3-PyEB (F, F) B (F, F) -OCF3 (No. 92) 4.0) 1-PyCF2OB (F) BF (No. 10) 4.0% 5-PyB (F, F) B (F, F) B (F) -CL (No. 129) 0% 3-B (F) B (F) PyB-F (No. 135) 4.0% 5-HB-F 12.0% 6-HB-F 9.0% 7-HB-F 7.0 % 5-HHB-OCF3 5.0% 3-HH2B-OCF3 4.0% 5-HH2B-OCF3 4.0% 3-HHB (F, F) -OCF3 5.0% 3-HBB (F) -F 10.0% 5-HBB (F) -F 10.0% 3-HH2B (F) -F 3.0% 3-HB (F) BH-3 3.0% 5- BBH-3 3.0% 3-HHB (F, F) -OCF2H 4.0%
【0083】 組成物例13 4−BPyB(F,F)B(F)−F (No.142) 3.0% 4−HPyB(F)B(F)−F (No.150) 3.0% 3−H2HB(F,F)−F 7.0% 5−H2HB(F,F)−F 8.0% 3−HHB(F,F)−F 10.0% 4−HHB(F,F)−F 5.0% 3−HH2B(F,F)−F 9.0% 5−HH2B(F,F)−F 9.0% 3−HBB(F,F)−F 15.0% 5−HBB(F,F)−F 15.0% 3−HBEB(F,F)−F 2.0% 4−HBEB(F,F)−F 2.0% 5−HBEB(F,F)−F 2.0% 3−HHEB(F,F)−F 10.0%Composition Example 13 4-BPyB (F, F) B (F) -F (No. 142) 3.0% 4-HPyB (F) B (F) -F (No. 150) 3.0 % 3-H2HB (F, F) -F 7.0% 5-H2HB (F, F) -F 8.0% 3-HHB (F, F) -F 10.0% 4-HHB (F, F ) -F 5.0% 3-HH2B (F, F) -F 9.0% 5-HH2B (F, F) -F 9.0% 3-HBB (F, F) -F 15.0% 5 -HBB (F, F) -F 15.0% 3-HBEB (F, F) -F 2.0% 4-HBEB (F, F) -F 2.0% 5-HBEB (F, F)- F 2.0% 3-HHEB (F, F) -F 10.0%
【0084】 組成物例14 F5−PyB(F,F)B(F)−F (No.10) 8.0% 5−PyB(F,F)B(F,F)EB(F)OCF2CFHCF3 (No.156) 4.0% 7−HB(F)−F 5.0% 5−H2B(F)−F 5.0% 3−HB−O2 10.0% 3−HH−4 2.0% 3−HH(5D,6D,7D)−4 3.0% 2−HHB(F)−F 10.0% 3−HHB(F)−F 10.0% 5−HH(5D,6D,7D)B(F)F 10.0% 3−H2HB(F)−F 5.0% 2−HBB(F)−F 3.0% 3−HBB(F)−F 3.0% 5−HBB(F)−F 6.0% 2−H2BB(F)−F 5.0% 3−H2BB(F)−F 6.0% 3−HHB−O1 5.0%Composition Example 14 F5-PyB (F, F) B (F) -F (No. 10) 8.0% 5-PyB (F, F) B (F, F) EB (F) OCF2CFHCF3 ( No. 156) 4.0% 7-HB (F) -F 5.0% 5-H2B (F) -F 5.0% 3-HB-O2 10.0% 3-HH-4 2.0% 3-HH (5D, 6D, 7D) -4 3.0% 2-HHB (F) -F 10.0% 3-HHB (F) -F 10.0% 5-HH (5D, 6D, 7D) B (F) F 10.0% 3-H2HB (F) -F 5.0% 2-HBB (F) -F 3.0% 3-HBB (F) -F 3.0% 5-HBB (F ) -F 6.0% 2-H2BB (F) -F 5.0% 3-H2BB (F) -F 6.0% 3-HHB-O1 5.0%
【0085】 組成物例15 5−PyB(F,F)B(F)−OCF3 (No.17) 12.0% 7−HB(F,F)−F 3.0% 3−H2HB(F,F)−F 12.0% 4−H2HB(F,F)−F 10.0% 5−H2HB(F,F)−F 10.0% 3−HHB(F,F)−F 5.0% 4−HHB(F,F)−F 5.0% 3−HH2B(F,F)−F 15.0% 5−HH2B(F,F)−F 10.0% 3−HBB(F,F)−F 12.0% 3−HBCF2OB(F,F)−F 6.0% TNI =71.9(℃) Δn =0.092 Δε =11.1 Vth =1.43(V) 上記の組成物100重量部に光学活性化合物(OP−
5)を0.25重量部添加した組成物のピッチは63.
0μmであった。Composition Example 15 5-PyB (F, F) B (F) -OCF3 (No. 17) 12.0% 7-HB (F, F) -F 3.0% 3-H2HB (F, F) -F 12.0% 4-H2HB (F, F) -F 10.0% 5-H2HB (F, F) -F 10.0% 3-HHB (F, F) -F 5.0% 4-HHB (F, F) -F 5.0% 3-HH2B (F, F) -F 15.0% 5-HH2B (F, F) -F 10.0% 3-HBB (F, F) -F 12.0% 3-HBCF2OB (F, F) -F 6.0% TNI = 71.9 (° C) Δn = 0.092 Δε = 11.1 Vth = 1.43 (V) The above composition 100 parts by weight of an optically active compound (OP-
The pitch of the composition containing 0.25 parts by weight of (5) is 63.
It was 0 μm.
【0086】 組成物例16 5−PyB(F,F)B(F)−OCF3 (No.17) 10.0% 7−HB(F,F)−F 5.0% 3−H2HB(F,F)−F 12.0% 4−H2HB(F,F)−F 10.0% 3−HHB(F,F)−F 10.0% 4−HHB(F,F)−F 5.0% 3−HBB(F,F)−F 10.0% 4−HHEB(F,F)−F 3.0% 5−HHEB(F,F)−F 3.0% 2−HBEB(F,F)−F 3.0% 3−HBEB(F,F)−F 5.0% 5−HBEB(F,F)−F 3.0% 3−HDB(F,F)−F 15.0% 3−HHBB(F,F)−F 6.0% TNI =70.9(℃) Δn =0.093 Δε =15.1 Vth =1.29(V)Composition Example 16 5-PyB (F, F) B (F) -OCF3 (No. 17) 10.0% 7-HB (F, F) -F 5.0% 3-H2HB (F, F) -F 12.0% 4-H2HB (F, F) -F 10.0% 3-HHB (F, F) -F 10.0% 4-HHB (F, F) -F 5.0% 3-HBB (F, F) -F 10.0% 4-HHEB (F, F) -F 3.0% 5-HHEB (F, F) -F 3.0% 2-HBEB (F, F) -F 3.0% 3-HBEB (F, F) -F 5.0% 5-HBEB (F, F) -F 3.0% 3-HDB (F, F) -F 15.0% 3- HHBB (F, F) -F 6.0% TNI = 70.9 (° C) Δn = 0.093 Δε = 15.1 Vth = 1.29 (V)
【0087】 組成物例17 5−PyB(F,F)B(F)−OCF3 (No.17) 5.0% 5−PyB(F)B(F,F)−F (No.1) 5.0% 5−H4HB(F,F)−F 7.0% 5−H4HB−OCF3 15.0% 3−H4HB(F,F)−CF3 8.0% 3−HB−CL 6.0% 5−HB−CL 4.0% 2−H2BB(F)−F 5.0% 3−H2BB(F)−F 10.0% 5−HVHB(F,F)−F 5.0% 3−HHB−OCF3 5.0% 3−H2HB−OCF3 5.0% V−HHB(F)−F 5.0% 3−HHB(F)−F 5.0% 5−HHEB−OCF3 2.0% 3−HBEB(F,F)−F 5.0% 5−HH−V2F 3.0%Composition Example 17 5-PyB (F, F) B (F) -OCF3 (No. 17) 5.0% 5-PyB (F) B (F, F) -F (No. 1) 5 5.0% 5-H4HB (F, F) -F 7.0% 5-H4HB-OCF3 15.0% 3-H4HB (F, F) -CF3 8.0% 3-HB-CL 6.0% 5 -HB-CL 4.0% 2-H2BB (F) -F 5.0% 3-H2BB (F) -F 10.0% 5-HVHB (F, F) -F 5.0% 3-HHB- OCF3 5.0% 3-H2HB-OCF3 5.0% V-HHB (F) -F 5.0% 3-HHB (F) -F 5.0% 5-HHEB-OCF3 2.0% 3-HBEB (F, F) -F 5.0% 5-HH-V2F 3.0%
【0088】 組成物例18 5−PyB(F,F)B(F)−OCF3 (No.17) 8.0% 5−HB−CL 12.0% 3−HH−4 7.0% 3−HB−O2 20.0% 3−H2HB(F,F)−F 8.0% 3−HBB(F,F)−F 6.0% 2−HHB(F)−F 5.0% 3−HHB(F)−F 5.0% 5−HHB(F)−F 5.0% 2−H2HB(F)−F 2.0% 3−H2HB(F)−F 1.0% 5−H2HB(F)−F 2.0% 3−HHBB(F,F)−F 4.0% 3−HBCF2OB−OCF3 4.0% 5−HBCF2OB(F,F)−CF3 4.0% 3−HHB−1 3.0% 3−HHB−O1 4.0% TNI =69.6(℃) Δn =0.093 Δε =5.8 Vth =1.99(V)Composition Example 18 5-PyB (F, F) B (F) -OCF3 (No. 17) 8.0% 5-HB-CL 12.0% 3-HH-4 7.0% 3- HB-O2 20.0% 3-H2HB (F, F) -F 8.0% 3-HBB (F, F) -F 6.0% 2-HHB (F) -F 5.0% 3-HHB (F) -F 5.0% 5-HHB (F) -F 5.0% 2-H2HB (F) -F 2.0% 3-H2HB (F) -F 1.0% 5-H2HB (F ) -F 2.0% 3-HHBB (F, F) -F 4.0% 3-HBCF2OB-OCF3 4.0% 5-HBCF2OB (F, F) -CF3 4.0% 3-HHB-13 0.0% 3-HHB-O1 4.0% TNI = 69.6 (° C.) Δn = 0.093 Δε = 5.8 Vth = 1.99 (V)
【0089】[0089]
【実施例】以下実施例により本発明をさらに詳しく説明
する。なお各実施例中において、Cは結晶、SAはスメ
クチックA相、Nはネマチック相、Iは等方性液体相を
それぞれ示す。The present invention will be described in more detail with reference to the following examples. In each example, C indicates a crystal, S A indicates a smectic A phase, N indicates a nematic phase, and I indicates an isotropic liquid phase.
【0090】実施例1 2−(4−(3−フルオロ−4−トリフルオロメトキシ
フェニル)−3,5−ジフルオロフェニル)−5−ペン
チルピリミジン(一般式(1)において、R=n−ペン
チル基、n1=0、n2=1、環B=(a)、Za=Zb
=Zc=単結合、Q1=Q3=Q4=Q6=Q7=水素原
子、Q2=Q5=フッ素原子、Y=OCF3である化合物
(No.17))の製造。Example 1 2- (4- (3-fluoro-4-trifluoromethoxyphenyl) -3,5-difluorophenyl) -5-pentylpyrimidine (in the formula (1), R = n-pentyl group , N1 = 0, n2 = 1, ring B = (a), Za = Zb
= Zc = single bond, Q 1 = Q 3 = Q 4 = Q 6 = Q 7 = hydrogen atom, Q 2 = Q 5 = fluorine atom, Y = OCF 3 (No. 17)).
【0091】(第一段)オキシ塩化リン11.48Kg
(74.9mol)をジメチルホルムアミド(DMF)
18.74Kg中に10℃で加え、そのままの温度で1
時間攪拌した。この粘着性の溶液に1,1−ジエトキシ
ヘプタン6.0Kg(31.9mol)のジクロロメタ
ン25l溶液を10℃で加え、そのままの温度で2時間
攪拌した後、30分間かけて70℃まで加温した。反応
液を冷却後、33.2Kgの炭酸カリウムと水100l
からなる水溶液中に30℃を越えないように徐々に加
え、室温で5時間攪拌した。生成物をクロロホルムで抽
出した。抽出液を飽和食塩水で洗浄し、無水硫酸マグネ
シウムで乾燥した後、溶媒を減圧にて留去した。残分を
蒸留により精製し、2−エトキシメチリデニルヘプタナ
ール2.6Kg(15.3mol)を得た。このものの
収率は48%であった。(First step) 11.48 kg of phosphorus oxychloride
(74.9 mol) in dimethylformamide (DMF)
Add at 18.degree. C. to 18.74 Kg, and
Stirred for hours. A solution of 6.0 kg (31.9 mol) of 1,1-diethoxyheptane in 25 l of dichloromethane was added to this viscous solution at 10 ° C., and the mixture was stirred at the same temperature for 2 hours, and then heated to 70 ° C. over 30 minutes. did. After cooling the reaction solution, 33.2 kg of potassium carbonate and 100 l of water were used.
The solution was gradually added to an aqueous solution consisting of not more than 30 ° C., and stirred at room temperature for 5 hours. The product was extracted with chloroform. The extract was washed with brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by distillation to obtain 2.6 kg (15.3 mol) of 2-ethoxymethylidenylheptanal. The yield was 48%.
【0092】(第二段)上記の2−エトキシメチリデニ
ルヘプタナール1197g(7.03mol)と尿素5
07g(8.44mol)をエタノール1l中で5分間
攪拌し、これを0℃まで冷却し、次いでこれに12N−
塩酸1lを滴下した後、この懸濁液を6時間加熱還流し
た。反応液を冷却後、2N−水酸化ナトリウム水溶液で
中和し、生成物をクロロホルムで抽出した。抽出液を水
で洗浄し、無水硫酸マグネシウムで乾燥した後、溶媒を
減圧にて留去した。残分をトルエンから再結晶して、2
−ヒドロキシ−5−ペンチルピリミジン972g(5.
86mol)を得た。このものの2−エトキシメチリデ
ニルヘプタナールからの収率は83%であった。(Second stage) 1197 g (7.03 mol) of the above 2-ethoxymethylidenylheptanal and urea 5
07 g (8.44 mol) were stirred in 1 liter of ethanol for 5 minutes, this was cooled to 0 ° C. and then 12N-
After dropwise adding 1 liter of hydrochloric acid, the suspension was heated to reflux for 6 hours. After cooling, the reaction solution was neutralized with a 2N aqueous solution of sodium hydroxide, and the product was extracted with chloroform. After the extract was washed with water and dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was recrystallized from toluene to give 2
972 g of -hydroxy-5-pentylpyrimidine (5.
86 mol). Its yield from 2-ethoxymethylidenylheptanal was 83%.
【0093】(第三段)オキシ塩化リン500ml中に
上記の2−ヒドロキシ−5−ペンチルピリミジン12
0.4g(0.724mol)を加え、5時間加熱還流
した。過剰のオキシ塩化リンを減圧にて留去し、残分を
氷水中に加えた。生成物をトルエンで抽出した。抽出液
を2N−水酸化ナトリウム、水でこの順に洗浄し、無水
硫酸マグネシウムで乾燥した後、減圧にて溶媒を留去し
た。残分を蒸留にて精製し、2−クロロ−5−ペンチル
ピリミジン76.3g(0.413mol)を得た。こ
のものの収率は57%であった。(Third stage) The above-mentioned 2-hydroxy-5-pentylpyrimidine 12 was dissolved in 500 ml of phosphorus oxychloride.
0.4 g (0.724 mol) was added, and the mixture was heated under reflux for 5 hours. Excess phosphorus oxychloride was distilled off under reduced pressure, and the residue was added to ice water. The product was extracted with toluene. The extract was washed with 2N-sodium hydroxide and water in this order, dried over anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was purified by distillation to obtain 76.3 g (0.413 mol) of 2-chloro-5-pentylpyrimidine. The yield was 57%.
【0094】(第四段)テトラヒドロフラン200ml
中で、乾燥したマグネシウムと3,5−ジフルオロブロ
モベンゼン49.0g(254mmol)とからグリニ
ヤール試薬を調製し、これにNiCl2(dppp)を
1g加えた後、上記の2−クロロ−5−ペンチルピリミ
ジン36.0g(195mmol)を滴下し、2時間加
熱還流した。反応液を冷却後、1N−塩酸200ml中
に加え、生成物をエーテルで抽出した。抽出液を、飽和
重曹水、水でこの順に洗浄し、無水マグネシウムで乾燥
した後、減圧にて溶媒を留去した。残分をシリカゲルカ
ラムクロマトグラフィー(展開溶媒:ヘプタン/トルエ
ン=1/1)により精製して、2−(3,5−ジフルオ
ロフェニル)−5−ペンチルピリミジン8.0g(30
mmol)を得た。このものの収率は15%であった。(Fourth stage) 200 ml of tetrahydrofuran
In the above, a Grignard reagent was prepared from dried magnesium and 49.0 g (254 mmol) of 3,5-difluorobromobenzene, 1 g of NiCl 2 (dppp) was added thereto, and then the above 2-chloro-5-pentyl was added. 36.0 g (195 mmol) of pyrimidine was added dropwise, and the mixture was heated under reflux for 2 hours. After cooling, the reaction mixture was added to 200 ml of 1N hydrochloric acid, and the product was extracted with ether. The extract was washed with saturated aqueous sodium hydrogen carbonate and water in this order, dried over anhydrous magnesium, and then the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: heptane / toluene = 1/1) to give 2- (3,5-difluorophenyl) -5-pentylpyrimidine (8.0 g, 30 g).
mmol). The yield was 15%.
【0095】(第五段)上記の2−(3,5−ジフルオ
ロフェニル)−5−ペンチルピリミジン8.0g(30
mmol)をTHF80mlに溶解し、窒素雰囲気下−
60℃に冷却した。この溶液にn−ブチルリチウムの
1.60Mヘキサン溶液20ml(32mmol)を液
温が−50℃を越えないように保って滴下し、そのまま
の温度で1時間攪拌した。次いでこの反応液に塩化亜鉛
の0.5M THF溶液64ml(32mmol)を液
温が−50℃を越えないように保って滴下した後、室温
まで加温し30分間攪拌した。この溶液にテトラキスト
リフェニルホスフィンパラジウム0.5gと3−フルオ
ロ−4−トリフルオロメトキシブロモベンゼン8.3g
(32mmol)とを加え、3時間加熱還流した。反応
液に水100mlを加え、生成物をトルエンで抽出し
た。抽出液を3N−塩酸、飽和重曹水および飽和食塩水
で順次洗浄し、硫酸マグネシウムで乾燥した後、溶媒を
留去した。残分をシリカゲルカラムクロマトグラフィー
(展開溶媒:ヘプタン/トルエン=1/1)により精製
した後、さらにヘプタン/酢酸エチル=1/1を用いて
2回再結晶処理して2−(4−(3−フルオロ−4−ト
リフルオロメトキシフェニル)−3,5−ジフルオロフ
ェニル)−5−ペンチルピリミジン0.09g(0.2
mmol)を得た。このものの2−(3,5−ジフルオ
ロフェニル)−5−ペンチルピリミジンからの収率は
0.7%であった。 1H−NMR(CDCl3)δ(ppm):8.65
(s,2H)、(8.21〜7.98(m,2H)、
7.50〜7.36(m,3H)、2.66(t,2
H)、1.79〜1.27(m,6H)、0.92
(t,3H)。 C−SA点 66.9℃、SA−I点82.1℃。(Fifth Stage) 8.0 g of the above 2- (3,5-difluorophenyl) -5-pentylpyrimidine (30 g)
mmol) in 80 ml of THF under a nitrogen atmosphere.
Cooled to 60 ° C. To this solution, 20 ml (32 mmol) of a 1.60 M hexane solution of n-butyllithium was added dropwise while keeping the liquid temperature not exceeding −50 ° C., and the mixture was stirred at that temperature for 1 hour. Next, 64 ml (32 mmol) of a 0.5 M THF solution of zinc chloride was added dropwise to the reaction solution while keeping the solution temperature not exceeding −50 ° C., followed by heating to room temperature and stirring for 30 minutes. 0.5 g of tetrakistriphenylphosphine palladium and 8.3 g of 3-fluoro-4-trifluoromethoxybromobenzene were added to this solution.
(32 mmol) and heated under reflux for 3 hours. 100 ml of water was added to the reaction solution, and the product was extracted with toluene. The extract was washed successively with 3N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated saline, dried over magnesium sulfate, and the solvent was distilled off. The residue was purified by silica gel column chromatography (developing solvent: heptane / toluene = 1/1) and then recrystallized twice using heptane / ethyl acetate = 1/1 to give 2- (4- (3 -Fluoro-4-trifluoromethoxyphenyl) -3,5-difluorophenyl) -5-pentylpyrimidine 0.09 g (0.2
mmol). Its yield from 2- (3,5-difluorophenyl) -5-pentylpyrimidine was 0.7%. 1H-NMR (CDCl 3 ) δ (ppm): 8.65
(S, 2H), (8.21 to 7.98 (m, 2H),
7.50 to 7.36 (m, 3H), 2.66 (t, 2
H) 1.79-1.27 (m, 6H), 0.92
(T, 3H). C-S A point 66.9 ° C, S A- I point 82.1 ° C.
【0096】実施例1および発明の詳細な説明の欄にお
ける記述を基に、下記の化合物No.1〜No.170
を製造することができる。なお実施例1の化合物も再掲
した。Based on the description in Example 1 and the column of the detailed description of the invention, the following compound No. 1 to No. 170
Can be manufactured. In addition, the compound of Example 1 was repeated.
【0097】[0097]
【化40】 Embedded image
【0098】[0098]
【化41】 Embedded image
【0099】[0099]
【化42】 Embedded image
【0100】[0100]
【化43】 Embedded image
【0101】[0101]
【化44】 Embedded image
【0102】[0102]
【化45】 Embedded image
【0103】[0103]
【化46】 Embedded image
【0104】[0104]
【化47】 Embedded image
【0105】[0105]
【化48】 Embedded image
【0106】[0106]
【化49】 Embedded image
【0107】[0107]
【化50】 Embedded image
【0108】[0108]
【化51】 Embedded image
【0109】[0109]
【化52】 Embedded image
【0110】[0110]
【化53】 Embedded image
【0111】[0111]
【化54】 Embedded image
【0112】[0112]
【化55】 Embedded image
【0113】[0113]
【化56】 Embedded image
【0114】 実施例2(使用例1) 4−(4−プロピルシクロヘキシル)ベンゾニトリル 24% 4−(4−ペンチルシクロヘキシル)ベンゾニトリル 36% 4−(4−ヘプチルシクロヘキシル)ベンゾニトリル 25% 4−(4−(4−ペンチルシクロヘキシル)フェニル)ベンゾニトリル 15% からなる液晶組成物(A)を調製した。このネマチック
液晶組成物は以下の物性値を有する。 TNI =71.7℃、 Vth =1.79V(セル厚9.2μmで測定) Δε =11.0、 Δn =0.137。 この液晶組成物(A1)の85重量%に実施例1の化合
物 2−(4−(3−フルオロ−4−トリフルオロメト
キシフェニル)−3,5−ジフルオロフェニル)−5−
ペンチルピリミジン(化合物No.17)を15重量%
混合して液晶組成物(B)を調製した。その物性値は以
下の通りであった。 TNI =68.2℃、 Vth =1.47V(セル厚8.9μmで測定) Δε =14.0、 Δn =0.142。 この組成物(B)は−20℃で30日間放置してもネマ
チック相を呈しており、なお上記液晶組成物(B)の物
性値と組成から外挿法で算出した上記(化合物No.1
7)の物性値は以下の通りであった。 TNI =48.4℃、 Δε =31.0、 Δn =0.170Example 2 (Use Example 1) 4- (4-propylcyclohexyl) benzonitrile 24% 4- (4-pentylcyclohexyl) benzonitrile 36% 4- (4-heptylcyclohexyl) benzonitrile 25% 4- ( A liquid crystal composition (A) comprising 15% of 4- (4-pentylcyclohexyl) phenyl) benzonitrile was prepared. This nematic liquid crystal composition has the following physical property values. TNI = 71.7 ° C., Vth = 1.79 V (measured at a cell thickness of 9.2 μm) Δε = 11.0, Δn = 0.137. The compound of Example 1 2- (4- (3-fluoro-4-trifluoromethoxyphenyl) -3,5-difluorophenyl) -5 was added to 85% by weight of the liquid crystal composition (A1).
15% by weight of pentylpyrimidine (Compound No. 17)
The mixture was mixed to prepare a liquid crystal composition (B). The physical properties were as follows. TNI = 68.2 ° C., Vth = 1.47 V (measured at 8.9 μm cell thickness) Δε = 14.0, Δn = 0.142. The composition (B) exhibited a nematic phase even after being left at −20 ° C. for 30 days.
Physical properties of 7) were as follows. TNI = 48.4 ° C., Δε = 31.0, Δn = 0.170
【0115】実施例3(比較例1) 上記液晶組成物(A)85重量%と特開平2−2336
26号に記載された2−(4−(3,4,5−トリフル
オロフェニル)フェニル)−5−ペンチルピリミジン
(化合物(10))15重量%とからなる液晶組成物
(B−R)を調製した。その物性値は以下の通りであっ
た。 TNI =73.5℃ Vth =1.60V(厚9.3μmで測定) Δε =12.3 Δn =0.147。 この組成物(B−R)は−20℃で保存すると、5日目
には結晶が発現した。なお上記液晶組成物(B−R)の
物性値と組成から外挿法で算出した上記化合物(10)
の物性値は以下の通りであった。 TNI =83.7℃ Δε =18.7 Δn =0.204 この結果から、化合物(10)と比べて、本発明の化合
物No.17はN−I転移点は約10℃低いが、Δεは
約1.7倍も大きく、かつ、他の液晶との低温相溶性も
良好であることがわかる。Example 3 (Comparative Example 1) 85% by weight of the liquid crystal composition (A) and JP-A-2-2336
A liquid crystal composition (BR) comprising 15% by weight of 2- (4- (3,4,5-trifluorophenyl) phenyl) -5-pentylpyrimidine (compound (10)) described in No. 26 was prepared. Prepared. The physical properties were as follows. TNI = 73.5 ° C. Vth = 1.60 V (measured at a thickness of 9.3 μm) Δε = 12.3 Δn = 0.147. When this composition (BR) was stored at -20 ° C, crystals appeared on the fifth day. The compound (10) calculated by extrapolation from the physical properties and composition of the liquid crystal composition (BR)
Were as follows. TNI = 83.7 ° C. Δε = 18.7 Δn = 0.204 From these results, it was found that Compound No. of the present invention was compared with Compound (10). 17 shows that although the NI transition point is about 10 ° C. lower, Δε is about 1.7 times as large, and the low-temperature compatibility with other liquid crystals is also good.
【0116】 実施例4 4−(2−(4−エチルシクロヘキシル)エチル)シクロヘキシル−3,4− ジフルオロベンゼン 40% 4−(2−(4−プロピルシクロヘキシル)エチル)シクロヘキシル−3,4 −ジフルオロベンゼン 20% 4−(2−(4−ペンチルシクロヘキシル)エチル)シクロヘキシル−3,4 −ジフルオロベンゼン 40% からなる液晶組成物(C)を調製した。この液晶組成物
(C)90重量%と2−(4−(3−フルオロ−4−ト
リフルオロメトキシフェニル)−3,5−ジフルオロフ
ェニル)−5−ペンチルピリミジン(化合物No.1
7)10重量%とからなる液晶組成物(D)を調製し
た。この液晶組成物(D)の電圧保持率は、25℃で9
7.5%、100℃で93.2%であった。Example 4 4- (2- (4-ethylcyclohexyl) ethyl) cyclohexyl-3,4-difluorobenzene 40% 4- (2- (4-propylcyclohexyl) ethyl) cyclohexyl-3,4-difluorobenzene A liquid crystal composition (C) comprising 20% of 40% of 4- (2- (4-pentylcyclohexyl) ethyl) cyclohexyl-3,4-difluorobenzene was prepared. 90% by weight of this liquid crystal composition (C) and 2- (4- (3-fluoro-4-trifluoromethoxyphenyl) -3,5-difluorophenyl) -5-pentylpyrimidine (Compound No. 1)
7) A liquid crystal composition (D) consisting of 10% by weight was prepared. The voltage holding ratio of this liquid crystal composition (D) was 9 at 25 ° C.
7.5% and 93.2% at 100 ° C.
【0117】実施例5(比較例2) 上記の液晶組成物(C)90重量%と2−(4−(3,
4,5−トリフルオロフェニル)フェニル)−5−ペン
チルピリミジン(化合物(10))10重量%とからな
る液晶組成物(D−R)を調製した。このものの電圧保
持率は25℃で97.5%、100℃で92.9%であ
った。したがって本発明の化合物(No.17)の電圧
保持率は既存のピリミジン誘導体である化合物(10)
と比較して何ら遜色ないことがわかる。Example 5 (Comparative Example 2) 90% by weight of the liquid crystal composition (C) and 2- (4- (3,3)
A liquid crystal composition (DR) was prepared which consisted of 10% by weight of (4,5-trifluorophenyl) phenyl) -5-pentylpyrimidine (compound (10)). Its voltage holding ratio was 97.5% at 25 ° C and 92.9% at 100 ° C. Therefore, the voltage holding ratio of the compound (No. 17) of the present invention is the compound (10) which is an existing pyrimidine derivative.
It turns out that there is no inferiority compared with.
【0118】実施例6 上記の液晶組成物(C)85重量%と 2−(4−(3
−フルオロ−4−トリフルオロメトキシフェニル)−
3,5−ジフルオロフェニル)−5−ペンチルピリミジ
ン(化合物No.17)15重量%とからなるて液晶組
成物(D2)を調製した。このものは−20℃で30日
間放置してもネマチック相を呈していた。Example 6 85% by weight of the liquid crystal composition (C) and 2- (4- (3
-Fluoro-4-trifluoromethoxyphenyl)-
3,5-Difluorophenyl) -5-pentylpyrimidine (Compound No. 17) in an amount of 15% by weight to prepare a liquid crystal composition (D2). The product exhibited a nematic phase even after being left at −20 ° C. for 30 days.
【0119】実施例7(比較例3) 上記の液晶組成物(C)95重量%と2−(4−(3−
フルオロ−4−トリフルオロメトキシフェニル)フェニ
ル)−5−ペンチルピリミジン(化合物10)5重量%
とからなる液晶組成物(D2−R)を調製した。このも
のは−20℃で30日間放置したところ結晶を発現して
いた。したがって本発明の化合物(No.17)のフッ
素置換された液晶化合物との低温相溶性は、公知の化合
物(10)のそれよりも優れていることがわかる。Example 7 (Comparative Example 3) 95% by weight of the liquid crystal composition (C) and 2- (4- (3-
5% by weight of fluoro-4-trifluoromethoxyphenyl) phenyl) -5-pentylpyrimidine (compound 10)
A liquid crystal composition (D2-R) consisting of When this was left at -20 ° C for 30 days, crystals appeared. Therefore, it can be seen that the low-temperature compatibility of the compound (No. 17) of the present invention with the fluorine-substituted liquid crystal compound is superior to that of the known compound (10).
【0120】[0120]
【発明の効果】本発明の化合物は、いずれも大きなΔε
と大きなΔnと比較的高い電圧保持率を有し、他の液晶
性化合物との低温相溶性も良好であることを特長とす
る。本発明の化合物を液晶組成物の構成成分として用い
ることにより、セル厚がよりいっそう薄いTFT型液晶
表示素子の製造が可能となる。The compounds of the present invention each have a large Δε
And a relatively high voltage holding ratio of Δn, and good low-temperature compatibility with other liquid crystal compounds. By using the compound of the present invention as a component of the liquid crystal composition, it is possible to produce a TFT type liquid crystal display device having a thinner cell thickness.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 富 嘉剛 千葉県市原市辰巳台東2丁目17番地 (72)発明者 竹下 房幸 千葉県君津市中富939番地5 (72)発明者 中川 悦男 千葉県市原市五井8890番地 ──────────────────────────────────────────────────の Continuing on the front page (72) Inventor Kago Tomi 2-17-17 Tatsumidaihigashi, Ichihara-shi, Chiba (72) Inventor Fusayuki Takeshita 939-5 Nakatomi, Kimitsu-shi, Chiba 5 (72) Inventor Etsuo Nakagawa Chiba 8890 Goi, Ichihara
Claims (16)
ル基を示すが、このアルキル基中の1個以上の水素原子
はハロゲン原子で置換されていてもよく、基中の1個以
上の−CH2−は酸素原子または−CH2=CH2−で置
換されていてもよいが、酸素原子が隣接することはな
く;n1およびn2はそれぞれ独立して0、1、または2
であるが、n1とn2の和は1または2であり;環Aおよ
び環Bはそれぞれに独立して1,4−フェニレン、式
(a)で表されるフッ素置換1,4−フェニレン、また
は1,4−シクロヘキシレンを示すが、環Aおよび環B
の少なくとも一方は式(a)で表されるフッ素置換1,
4−フェニレンであり、かつこのフッ素置換1,4−フ
ェニレンに対応するn1および/またはn2は1または2
であり、1,4−シクロヘキシレンは基中の相隣接しな
い1個以上の−CH2−は酸素原子で置換されていても
よく、また1,4−シクロヘキシレンは基中の1個以上
の水素原子はハロゲン原子で置換されていてもよく;Z
a、Zb、およびZcはそれぞれに独立して単結合、−
CH2CH2−、−COO−、−CF2O−あるいは−C
H2CH2CH2CH2−を示し;Q1、Q2、Q3、Q4、Q
5、Q6およびQ7はそれぞれに独立して水素原子、ハロ
ゲン原子あるいはメチル基を示すが、Za、Zbおよび
Zcの少なくとも1個が−CH2CH2−の場合はQ2は
フッ素原子であり;Yは水素原子、ハロゲン原子、また
は炭素数1〜5のハロゲン化アルキル基を示すが、この
ハロゲン化アルキル基中の相隣接しない1つ以上のメチ
レン基は酸素原子あるいは硫黄原子で置換されていても
よく;また、この化合物を構成する各元素はその同位体
で置換されていてもよい。)で表されるピリミジン誘導
体。1. A compound of the general formula (1) (In the formula, R represents a hydrogen atom or an alkyl group having 1 to 20 carbon atoms. One or more hydrogen atoms in the alkyl group may be substituted with a halogen atom, and one or more hydrogen atoms in the group may be substituted. of -CH 2 - is an oxygen atom or -CH 2 = CH 2 - may be substituted with, but instead that the oxygen atom adjacent; n1 and n2 are each independently 0, 1 or 2,
Wherein the sum of n1 and n2 is 1 or 2; ring A and ring B are each independently 1,4-phenylene, a fluorine-substituted 1,4-phenylene represented by formula (a), or 1,4-cyclohexylene, wherein ring A and ring B
At least one of the fluorine-substituted 1, represented by the formula (a)
N 1 and / or n 2 corresponding to the fluorine-substituted 1,4-phenylene are 1 or 2
1,4-cyclohexylene may have one or more non-adjacent —CH 2 — in the group optionally substituted with an oxygen atom, and 1,4-cyclohexylene has one or more A hydrogen atom may be replaced by a halogen atom;
a, Zb, and Zc are each independently a single bond,-
CH 2 CH 2 -, - COO -, - CF 2 O- or -C
H 2 CH 2 CH 2 CH 2 - indicates; Q 1, Q 2, Q 3, Q 4, Q
5 , Q 6 and Q 7 each independently represent a hydrogen atom, a halogen atom or a methyl group, but when at least one of Za, Zb and Zc is —CH 2 CH 2 —, Q 2 is a fluorine atom Y represents a hydrogen atom, a halogen atom, or a halogenated alkyl group having 1 to 5 carbon atoms, wherein one or more non-adjacent methylene groups in the halogenated alkyl group are substituted with an oxygen atom or a sulfur atom. And each element constituting the compound may be substituted with its isotope. A) a pyrimidine derivative represented by the formula:
り、n2が1であり、Za、ZbおよびZcがすべて単
結合であり、Q1とQ3が共に水素原子であり、Q2がフ
ッ素原子である請求項1に記載のピリミジン誘導体。2. A general formula (1), n1 is 0, n2 is 1, Za, a Zb and Zc are all single bonds, Q 1 and Q 3 are both hydrogen atoms, Q 2 The pyrimidine derivative according to claim 1, wherein is a fluorine atom.
り、n2が1であり、Za、ZbおよびZcがすべて単
結合であり、Q1、Q2およびQ3がすべて水素原子であ
る請求項1に記載のピリミジン誘導体。3. In the general formula (1), n1 is 0, n2 is 1, Za, Zb and Zc are all single bonds, and Q 1 , Q 2 and Q 3 are all hydrogen atoms. The pyrimidine derivative according to claim 1.
り、n2が0である請求項1に記載のピリミジン誘導
体。4. The pyrimidine derivative according to claim 1, wherein in formula (1), n1 is 1 and n2 is 0.
り、n2が1であり、ZaおよびZbが共に単結合であ
り、Zcが−COO−または−CF2O−である請求項
1に記載のピリミジン誘導体。5. The general formula (1), n1 is 0, n 2 is 1, Za and Zb are both single bonds, claim Zc is -COO- or -CF 2 O-a is 2. The pyrimidine derivative according to 1.
り、n2が1であり、ZaおよびZcが共に単結合であ
り、Zbが−COO−または−CF2O−である請求項
1に記載のピリミジン誘導体。6. In the general formula (1), n1 is 0, n2 is 1, Za and Zc are each a single bond, and Zb is —COO— or —CF 2 O—. The pyrimidine derivative according to the above.
ある請求項1に記載のピリミジン誘導体。7. The pyrimidine derivative according to claim 1, wherein in the general formula (1), n1 + n2 = 2.
以上の水素原子がフッ素原子で置換されたアルキル基で
ある請求項1に記載のピリミジン誘導体。8. The pyrimidine derivative according to claim 1, wherein in the general formula (1), R is an alkyl group in which one or more hydrogen atoms in the group have been substituted with fluorine atoms.
ピリミジン誘導体を少なくとも1種類含有することを特
徴とする液晶組成物。9. A liquid crystal composition comprising at least one pyrimidine derivative according to any one of claims 1 to 8.
ずれか1項に記載のピリミジン誘導体を少なくとも1種
類含有し、第二成分として、一般式(2)、(3)およ
び(4) 【化2】 (各式中、R3、Y1、L1、L2、Z1およびZ2は各式間
で同一または互いに異なっていてもよく、R3は炭素数
1〜10のアルキル基であり、このアルキル基中の相隣
接しない一つ以上のメチレン基は酸素原子または−CH
=CH−で置換されていてもよく、またこの基中の任意
の水素原子はフッ素原子で置換されてもよく;Y1はフ
ッ素原子、塩素原子、−OCF3、−OCF2H、−CF
3、−CF2H、−CFH2、−OCF2CF2H、または
−OCF2CFHCF3を示し;L1およびL2は各々独立
して水素原子またはフッ素原子を示し;Z1およびZ2は
各々独立して−CH2CH2−、−CH2CH2CH2CH2
−、−COO−、−CF2O−、−OCF2−、−CH=
CH−、または単結合を示し;環Bはトランスー1,4
−シクロヘキシレン、1,3−ジオキサン−2,5−ジ
イル、または水素原子がフッ素原子で置換されてもよい
1,4−フェニレンを示し;環Cはトランスー1,4−
シクロヘキシレン、または水素原子がフッ素原子で置換
されてもよい1,4−フェニレンを示し;また、これら
の化合物を構成する各原子はその同位体で置換されてい
てもよい。)からなる化合物群から選択される化合物を
少なくとも1種類含有することを特徴とする液晶組成
物。10. The first component contains at least one pyrimidine derivative according to any one of claims 1 to 8, and the second component has a general formula (2), (3) or (4). Embedded image (In each formula, R 3 , Y 1 , L 1 , L 2 , Z 1 and Z 2 may be the same or different between each formula, and R 3 is an alkyl group having 1 to 10 carbon atoms; One or more non-adjacent methylene groups in the alkyl group may be an oxygen atom or -CH
CHCH— and any hydrogen atom in this group may be replaced by a fluorine atom; Y 1 is a fluorine atom, a chlorine atom, —OCF 3 , —OCF 2 H, —CF
3, -CF 2 H, -CFH 2 , -OCF 2 CF 2 H, or show the -OCF 2 CFHCF 3; L 1 and L 2 each independently represents a hydrogen atom or a fluorine atom; Z 1 and Z 2 -CH 2 CH 2 independently each -, - CH 2 CH 2 CH 2 CH 2
-, - COO -, - CF 2 O -, - OCF 2 -, - CH =
CH- or a single bond; Ring B is trans-1,4
-Cyclohexylene, 1,3-dioxane-2,5-diyl or 1,4-phenylene in which a hydrogen atom can be replaced by a fluorine atom; ring C is trans-1,4-
Cyclohexylene or 1,4-phenylene in which a hydrogen atom may be substituted by a fluorine atom; and each atom constituting these compounds may be substituted by its isotope. A) a liquid crystal composition comprising at least one compound selected from the group consisting of:
ずれか1項に記載の化合物を少なくとも1種類含有し、
第二成分として、一般式(5)および(6) 【化3】 (各式中、R4およびR5は各々独立して炭素数1〜10
のアルキル基を示すが、該アルキル基中の相隣接しない
一つ以上のメチレン基は酸素原子または−CH=CH−
で置換されていてもよく、またこの基中の水素原子はフ
ッ素原子で置換されてもよく;Y2は−CN、または−
C≡C−CNを示し;環Eはトランスー1,4−シクロ
ヘキシレン、1,4−フェニレン、1,3−ジオキサン
−2,5−ジイル、またはピリミジン−2,5−ジイル
を示し;環Gはトランスー1,4−シクロヘキシレン、
ピリミジン−2,5−ジイル、または水素原子がフッ素
原子で置換されていてもよい1,4−フェニレンを示
し;環Hはトランスー1,4−シクロヘキシレンまたは
1,4−フェニレンを示し、Z3は−CH2CH2−、−
COO−または単結合を示し;L3、L4およびL5は各
々独立して水素原子またはフッ素原子を示し;b、cお
よびdは各々独立して0または1であり;また、これら
の化合物を構成する各元素はその同位体で置換されてい
てもよい。)からなる化合物群から選択される化合物を
少なくとも1種類含有することを特徴とする液晶組成
物。11. A compound comprising at least one compound according to any one of claims 1 to 8 as a first component,
As the second component, general formulas (5) and (6) (In each formula, R 4 and R 5 are each independently a C 1-10
Wherein one or more non-adjacent methylene groups in the alkyl group are an oxygen atom or -CH = CH-
And a hydrogen atom in this group may be replaced by a fluorine atom; Y 2 represents —CN, or —.
Ring E represents trans-1,4-cyclohexylene, 1,4-phenylene, 1,3-dioxane-2,5-diyl or pyrimidine-2,5-diyl; ring G represents Is trans-1,4-cyclohexylene,
Pyrimidine-2,5-diyl or 1,4-phenylene in which a hydrogen atom may be replaced by a fluorine atom; ring H represents trans-1,4-cyclohexylene or 1,4-phenylene, and Z 3 It is -CH 2 CH 2 -, -
L 3 , L 4 and L 5 each independently represent a hydrogen atom or a fluorine atom; b, c and d each independently represent 0 or 1; May be substituted by its isotope. A) a liquid crystal composition comprising at least one compound selected from the group consisting of:
ずれか1項に記載の化合物を少なくとも1種類含有し、
第二成分として、上記一般式(2)、(3)および
(4)からなる化合物群から選択される化合物を少なく
とも1種類含有し、第三成分として、一般式(7)、
(8)および(9) 【化4】 (各式中、R6、R7、I、JおよびKは各式間で同一ま
たは互いに異なっていてもよく、R6およびR7は各々独
立して炭素数1〜10のアルキル基を示し、このアルキ
ル基中の相隣接しない一つ以上のメチレン基は酸素原子
または−CH=CH−で置換されていてもよく、またこ
の基中の任意の水素原子はフッ素原子で置換されてもよ
く;環I、環Jおよび環Kは各々独立して、トランスー
1,4−シクロヘキシレン、ピリミジン−2,5−ジイ
ル、または水素原子がフッ素原子で置換されてもよい
1,4−フェニレンを示し;Z4およびZ5は各々独立し
て、−C≡C−、−COO−、−CH2CH2−、−CH
=CH−または単結合を示し;また、これらの化合物を
構成する各原子はその同位体で置換されていてもよ
い。)からなる化合物群から選択される化合物を少なく
とも1種類含有することを特徴とする液晶組成物。12. A compound comprising at least one compound according to claim 1 as a first component,
The second component contains at least one compound selected from the compound group consisting of the general formulas (2), (3) and (4), and the third component has a general formula (7)
(8) and (9) (In each formula, R 6 , R 7 , I, J and K may be the same or different between each formula, and R 6 and R 7 each independently represent an alkyl group having 1 to 10 carbon atoms. One or more non-adjacent methylene groups in the alkyl group may be substituted with an oxygen atom or -CH = CH-, and any hydrogen atom in the group may be substituted with a fluorine atom. Ring I, ring J and ring K each independently represent trans-1,4-cyclohexylene, pyrimidine-2,5-diyl or 1,4-phenylene in which a hydrogen atom may be substituted by a fluorine atom; ; Z 4 and Z 5 are each independently, -C≡C -, - COO -, - CH 2 CH 2 -, - CH
= CH- or a single bond; each atom constituting these compounds may be substituted with its isotope. A) a liquid crystal composition comprising at least one compound selected from the group consisting of:
ずれか1項に記載の化合物を少なくとも1種類含有し、
第二成分として、上記一般式(5)および(6)からな
る化合物群から選択される化合物を少なくとも1種類含
有し、第三成分として、上記一般式(7)、(8)およ
び(9)からなる化合物群から選択される化合物を少な
くとも1種類含有することを特徴とする液晶組成物。13. A compound comprising at least one compound according to claim 1 as a first component,
As the second component, at least one compound selected from the compound group consisting of the general formulas (5) and (6) is contained, and as the third component, the general formulas (7), (8) and (9) are included. A liquid crystal composition comprising at least one compound selected from the group consisting of:
ずれか1項に記載の化合物を少なくとも1種類含有し、
第二成分の一部分として、上記一般式(2)、(3)お
よび(4)からなる化合物群から選択される化合物を少
なくとも1種類含有し、第二成分の他の部分として上記
一般式(5)および(6)からなる化合物群から選択さ
れる化合物を少なくとも1種類含有し、第三成分とし
て、一般式(7)、(8)および(9)からなる化合物
群から選択される化合物を少なくとも1種類含有するこ
とを特徴とする液晶組成物。14. A compound comprising at least one compound according to claim 1 as a first component,
As a part of the second component, at least one compound selected from the compound group consisting of the general formulas (2), (3), and (4) is contained, and as another part of the second component, the general formula (5) ) And at least one compound selected from the compound group consisting of (6), and as a third component, at least a compound selected from the compound group consisting of general formulas (7), (8) and (9) A liquid crystal composition comprising one type.
載の液晶組成物に、さらに1種類以上の光学活性化合物
を含有することを特徴とする液晶組成物。15. A liquid crystal composition according to claim 9, further comprising one or more optically active compounds.
載の液晶組成物を用いて構成した液晶表示素子。16. A liquid crystal display device comprising the liquid crystal composition according to claim 9. Description:
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9197821A JPH1129557A (en) | 1997-07-08 | 1997-07-08 | Pyrimidine derivative, liquid crystal composition containing the same and liquid crystal display element using the same |
| US09/203,671 US6326065B1 (en) | 1997-07-08 | 1998-12-01 | Pyrimidine derivative, liquid crystal composition comprising the derivative, and liquid crystal display device fabricated by using the composition |
| EP98250419A EP1006109A1 (en) | 1997-07-08 | 1998-12-01 | Pyrimidine derivative, liquid crystal composition comprising the derivative, and liquid crystal display device fabricated by using the composition |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9197821A JPH1129557A (en) | 1997-07-08 | 1997-07-08 | Pyrimidine derivative, liquid crystal composition containing the same and liquid crystal display element using the same |
| US09/203,671 US6326065B1 (en) | 1997-07-08 | 1998-12-01 | Pyrimidine derivative, liquid crystal composition comprising the derivative, and liquid crystal display device fabricated by using the composition |
| EP98250419A EP1006109A1 (en) | 1997-07-08 | 1998-12-01 | Pyrimidine derivative, liquid crystal composition comprising the derivative, and liquid crystal display device fabricated by using the composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH1129557A true JPH1129557A (en) | 1999-02-02 |
Family
ID=27239481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9197821A Pending JPH1129557A (en) | 1997-07-08 | 1997-07-08 | Pyrimidine derivative, liquid crystal composition containing the same and liquid crystal display element using the same |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US6326065B1 (en) |
| EP (1) | EP1006109A1 (en) |
| JP (1) | JPH1129557A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007161995A (en) * | 2005-11-16 | 2007-06-28 | Chisso Corp | Liquid crystal composition and liquid crystal display element |
| WO2009139330A1 (en) * | 2008-05-15 | 2009-11-19 | チッソ株式会社 | Optically isotropic liquid crystalline medium, and optical element |
| JP2009282534A (en) * | 2001-05-16 | 2009-12-03 | Merck Patent Gmbh | Electro-optic light control element, display and medium |
| JP2010525115A (en) * | 2007-04-24 | 2010-07-22 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Liquid crystal medium and liquid crystal display |
| KR20110070988A (en) * | 2008-10-21 | 2011-06-27 | 제이엔씨 주식회사 | 5-ring liquid crystal compound, liquid crystal composition and liquid crystal display device having a nitrogen-containing heterocycle |
| KR20140053231A (en) * | 2011-08-01 | 2014-05-07 | 메르크 파텐트 게엠베하 | Liquid crystal medium and liquid crystal display |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000109842A (en) * | 1998-10-07 | 2000-04-18 | Chisso Corp | Liquid crystal medium and electro-optical liquid crystal display |
| US7563492B2 (en) | 2005-11-16 | 2009-07-21 | Chisso Corporation | Liquid crystal composition and liquid crystal display device |
| EP2568032B1 (en) | 2011-09-06 | 2014-11-26 | Merck Patent GmbH | Liquid crystal medium and liquid crystal display |
| KR101983867B1 (en) | 2011-09-06 | 2019-05-29 | 메르크 파텐트 게엠베하 | Liquid crystal medium and liquid crystal display |
| EP2708587B1 (en) | 2012-09-18 | 2015-07-15 | Merck Patent GmbH | Liquid crystal medium and liquid crystal display |
| KR102162137B1 (en) | 2012-10-02 | 2020-10-06 | 메르크 파텐트 게엠베하 | Liquid crystal medium and liquid crystal display |
| CN108130101B (en) * | 2014-11-20 | 2021-05-25 | 北京八亿时空液晶科技股份有限公司 | A kind of liquid crystal compound containing difluoromethoxy bridge bond and its application |
| CN104479688B (en) * | 2014-11-27 | 2016-06-29 | 北京八亿时空液晶科技股份有限公司 | A kind of containing the liquid-crystal compounds of difluoro-methoxy bridged bond, compositions and application thereof |
| CN104673323B (en) * | 2015-02-04 | 2016-09-21 | 北京八亿时空液晶科技股份有限公司 | A kind of liquid-crystal composition containing 2-methyl-3,4,5-trifluoro-benzene liquid-crystal compounds and application thereof |
| CN109722258B (en) * | 2017-10-27 | 2020-09-29 | 北京八亿时空液晶科技股份有限公司 | Liquid crystal composition containing pentenyl compound and application thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61197563A (en) * | 1985-02-27 | 1986-09-01 | Chisso Corp | Pyrimidine derivative having trifluoromethylphenyl group |
| DE3731639A1 (en) * | 1987-09-19 | 1989-03-30 | Hoechst Ag | LIQUID CRYSTALLINE PHENYLPYRIMIDINE CYCLOHEXANCARBOXY ACID ESTERS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN LIQUID CRYSTAL MIXTURES |
| DE68926635T2 (en) * | 1988-04-25 | 1997-01-02 | Dainippon Ink & Chemicals | 2,5-disubstituted pyrazine derivatives, pyrimidine derivatives and liquid crystals containing them |
| JP2696557B2 (en) * | 1989-03-07 | 1998-01-14 | チッソ株式会社 | Trifluorobenzene derivative |
| EP0391591B1 (en) * | 1989-04-06 | 1994-06-15 | Seiko Epson Corporation | Pyrimidine derivative and liquid crystal composition incorporating the same |
| US5482650A (en) * | 1992-04-28 | 1996-01-09 | Minnesota Mining And Manufacturing Company | Liquid crystal compounds having perfluoroether terminal portions |
| DE4409431B4 (en) * | 1993-04-03 | 2006-06-29 | Merck Patent Gmbh | Cyanophenylpyri (mi) din derivatives and liquid crystalline medium |
| JP3187611B2 (en) * | 1993-05-17 | 2001-07-11 | キヤノン株式会社 | Liquid crystal compound, liquid crystal composition containing the same, liquid crystal element having the same, display method and display device using them |
| JPH07101894A (en) * | 1993-10-05 | 1995-04-18 | Canon Inc | Optically active compound, liquid crystal composition containing the same, liquid crystal device using the same, display method and display device |
| DE19513007A1 (en) * | 1994-04-14 | 1995-10-19 | Merck Patent Gmbh | Fluoro-phenyl hexa:fluoro-propyl ethers useful in liquid crystal media |
| JP3119340B2 (en) * | 1995-01-31 | 2000-12-18 | キヤノン株式会社 | Liquid crystal composition, liquid crystal element having the same, and liquid crystal device having the same |
| GB9620060D0 (en) * | 1996-09-26 | 1996-11-13 | Secr Defence | Liquid crystal compounds, mixtures and devices |
| JP4091987B2 (en) * | 1996-11-28 | 2008-05-28 | チッソ株式会社 | Chlorobenzene derivative, liquid crystal composition, and liquid crystal display device |
-
1997
- 1997-07-08 JP JP9197821A patent/JPH1129557A/en active Pending
-
1998
- 1998-12-01 EP EP98250419A patent/EP1006109A1/en not_active Withdrawn
- 1998-12-01 US US09/203,671 patent/US6326065B1/en not_active Expired - Fee Related
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009282534A (en) * | 2001-05-16 | 2009-12-03 | Merck Patent Gmbh | Electro-optic light control element, display and medium |
| JP2007161995A (en) * | 2005-11-16 | 2007-06-28 | Chisso Corp | Liquid crystal composition and liquid crystal display element |
| JP2010525115A (en) * | 2007-04-24 | 2010-07-22 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Liquid crystal medium and liquid crystal display |
| KR101533467B1 (en) * | 2007-04-24 | 2015-07-02 | 메르크 파텐트 게엠베하 | Liquid crystal medium and liquid crystal display |
| WO2009139330A1 (en) * | 2008-05-15 | 2009-11-19 | チッソ株式会社 | Optically isotropic liquid crystalline medium, and optical element |
| JP5408130B2 (en) * | 2008-05-15 | 2014-02-05 | Jnc株式会社 | Optically isotropic liquid crystal medium and optical element |
| TWI470065B (en) * | 2008-05-15 | 2015-01-21 | Jnc Corp | Optical isotropy liquid crystal medium and optical device |
| KR20110070988A (en) * | 2008-10-21 | 2011-06-27 | 제이엔씨 주식회사 | 5-ring liquid crystal compound, liquid crystal composition and liquid crystal display device having a nitrogen-containing heterocycle |
| JP5582035B2 (en) * | 2008-10-21 | 2014-09-03 | Jnc株式会社 | Pentacyclic liquid crystal compound having nitrogen-containing heterocycle, liquid crystal composition, and liquid crystal display device |
| KR20140053231A (en) * | 2011-08-01 | 2014-05-07 | 메르크 파텐트 게엠베하 | Liquid crystal medium and liquid crystal display |
| JP2014527105A (en) * | 2011-08-01 | 2014-10-09 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Liquid crystal medium and liquid crystal display |
Also Published As
| Publication number | Publication date |
|---|---|
| US6326065B1 (en) | 2001-12-04 |
| EP1006109A1 (en) | 2000-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3287288B2 (en) | Polyhaloalkyl ether derivatives, liquid crystal compositions containing them and liquid crystal display devices | |
| JP2959526B2 (en) | Phenyldioxane derivative, liquid crystal composition and liquid crystal display device | |
| JP3646671B2 (en) | Liquid crystal compound, liquid crystal composition containing the liquid crystal compound, and liquid crystal display device using the liquid crystal composition | |
| JP4096123B2 (en) | Compound having alkadienyl group as side chain, and liquid crystal composition using the same | |
| JP5267083B2 (en) | Dioxane derivative, liquid crystal composition containing the same, and liquid crystal display device using the same | |
| JPWO1997036847A1 (en) | Liquid crystal compound, liquid crystal composition containing the liquid crystal compound, and liquid crystal display element using the liquid crystal composition | |
| JP4432123B2 (en) | Liquid crystal compound, liquid crystal composition containing the same, and liquid crystal display device using the same | |
| US20020038858A1 (en) | Difluorophenyl derivatives, liquid-crystal compounds, and liquid-crystal composition | |
| JPWO1998023564A1 (en) | Fluorine-substituted benzene derivative, liquid crystal composition and liquid crystal display element | |
| JPWO1998017664A1 (en) | Dioxane derivative, liquid crystal composition containing the same, and liquid crystal display element using the same | |
| JPWO1998032721A1 (en) | Liquid crystal compound, liquid crystal composition containing the same, and liquid crystal display element using the same | |
| US6326065B1 (en) | Pyrimidine derivative, liquid crystal composition comprising the derivative, and liquid crystal display device fabricated by using the composition | |
| JP2001302568A (en) | Cyclohexane derivative, liquid crystal composition containing the same, and liquid crystal display device | |
| JPH10139778A (en) | Dioxane derivative having fluoroalkyl group, liquid crystal composition and liquid crystal display element | |
| JPH1087543A (en) | Alkoxybenzene derivative, liquid crystal composition, and liquid crystal display element | |
| JP2005298466A (en) | Compound having perfluoropropenyl, liquid crystal composition, and liquid crystal display device | |
| EP1352886B1 (en) | Liquid crystal compound having hydrogen as a terminal group, composition comprising the compound, and liquid crystal display element comprising the composition | |
| JP4311055B2 (en) | Liquid crystalline compound in which one of terminal groups is hydrogen, composition thereof, and liquid crystal display device containing the same | |
| EP0861828A1 (en) | Liquid crystalline compounds containing hydrocarbon groups, liquid crystalline compositions and liquid crystal display elements | |
| JP4742210B2 (en) | Acid fluoride derivative and liquid crystal composition containing the same | |
| JP4660916B2 (en) | Liquid crystal compound having a piperidine ring, liquid crystal composition, and liquid crystal display device | |
| EP1160251A2 (en) | Liquid crystalline compounds having a silane diyl group, liquid crystal compositions comprising the same and liquid crystal display devices | |
| JP4075105B2 (en) | Novel liquid crystalline compound having a difluoromethyleneoxy group, liquid crystal composition and liquid crystal display | |
| JP3935954B2 (en) | Difluorophenyl derivative, liquid crystal composition, and liquid crystal display device | |
| JP2000159744A (en) | Fluoroalkylthioether compound, liquid crystal composition, and liquid crystal display device |